_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725204471,5/23/2015 14:57:48,1642204015,5/23/2015 14:57:34,false,elite,1,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],Treatment of,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 14:59:28,1642204512,5/23/2015 14:59:18,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],Treatment,-,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:02:46,1642205316,5/23/2015 15:02:29,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],Treatment of,n/a,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:06:54,1642206303,5/23/2015 15:06:16,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment AIDS DIDEOXYINOSINE given daily.,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:08:36,1642206702,5/23/2015 15:08:12,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],Treatment with,n/a,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:08:38,1642206712,5/23/2015 15:08:12,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Treatment,none,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:09:01,1642206810,5/23/2015 15:08:45,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment of,n/a,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:09:22,1642206961,5/23/2015 15:08:31,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],DIDEOXYINOSINE,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:10:49,1642207369,5/23/2015 15:10:21,false,prodege,1,1919444,GBR,D1,Darlington,86.22.61.205,[TREATS],[TREATS],given once daily.,NA,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:12:59,1642208217,5/23/2015 15:11:37,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",n/a,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:13:00,1642208229,5/23/2015 15:11:21,false,neodev,1,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:13:15,1642208324,5/23/2015 15:11:58,false,prodege,1,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],Treatment of,N/a,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:26:25,1642212333,5/23/2015 15:24:56,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:30:39,1642213271,5/23/2015 15:30:06,false,instagc,1,18805669,CAN,ON,Toronto,76.10.153.80,[TREATS],[TREATS],Treatment AIDS DIDEOXYINOSINE,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204471,5/23/2015 15:32:47,1642213777,5/23/2015 15:32:23,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,55,96,-1,58,110,TWrex-cause,800526-FS1,"Cooley TP, Kunches LM, Saunders CA et al. Treatment of AIDS and AIDS related complex with 2′,3′ DIDEOXYINOSINE given once daily.",AIDS,DIDEOXYINOSINE
725204472,5/23/2015 14:55:35,1642203437,5/23/2015 14:55:17,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[IS_A],[IS_A],is graded as,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 14:56:40,1642203792,5/23/2015 14:56:25,false,neodev,1,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 14:56:45,1642203809,5/23/2015 14:56:07,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[IS_A],[IS_A],is graded as,-,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 14:58:20,1642204198,5/23/2015 14:57:41,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[IS_A],[IS_A],graded,n/a,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:01:16,1642204903,5/23/2015 15:00:26,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],is graded as,n/a,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:01:33,1642204954,5/23/2015 15:00:55,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",graded (severe dysplasia carCINoma,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:01:51,1642205083,5/23/2015 15:01:09,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],dysplasia,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:02:32,1642205250,5/23/2015 15:01:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]","CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",n/a,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:04:10,1642205684,5/23/2015 15:03:40,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],graded as,none,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:04:46,1642205866,5/23/2015 15:04:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],is graded as,n/a,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:06:29,1642206202,5/23/2015 15:05:31,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in situ.,NA,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:07:10,1642206357,5/23/2015 15:06:41,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is or,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:07:15,1642206379,5/23/2015 15:06:49,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[PART_OF],[PART_OF],CIN is graded as (MILD CERVICAL DYSPLASIA),N/a,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:10:56,1642207432,5/23/2015 15:10:33,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,CIN is not a valid term,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204472,5/23/2015 15:22:22,1642211050,5/23/2015 15:22:03,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[IS_A],[IS_A],graded,N/A,20,0,1,42,3,TWrex-cause,814926-FS1,"CIN is graded as 1 (MILD CERVICAL DYSPLASIA) 2 (moderate dysplasia), or 3 (severe dysplasia and carCINoma in situ.",MILD CERVICAL DYSPLASIA,CIN
725204473,5/23/2015 14:58:19,1642204202,5/23/2015 14:58:09,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 14:59:52,1642204619,5/23/2015 14:59:42,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:07:57,1642206500,5/23/2015 15:07:27,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],DISEASE caused by RICKETTSIA AKARI.,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:09:20,1642206957,5/23/2015 15:09:00,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:09:45,1642207039,5/23/2015 15:09:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:11:43,1642207720,5/23/2015 15:11:03,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[PREVENTS],[PREVENTS],DISEASE,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:13:58,1642208566,5/23/2015 15:13:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",An caused by,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:14:53,1642208811,5/23/2015 15:13:40,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CAUSES],[CAUSES],caused by,N/a,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:14:56,1642208848,5/23/2015 15:14:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"rickettsialpox An acute, febrile, SELF LIMITED DISEASE caused by RICKETTSIA AKARI.",n/a,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:30:56,1642213334,5/23/2015 15:30:37,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:31:19,1642213410,5/23/2015 15:30:55,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",An caused by,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:31:24,1642213425,5/23/2015 15:31:05,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],rickettsialpox SELF LIMITED DISEASE caused RICKETTSIA AKARI.,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:35:52,1642214630,5/23/2015 15:35:03,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],RICKETTSIA AKARI.,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:38:46,1642215572,5/23/2015 15:37:42,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204473,5/23/2015 15:40:30,1642216080,5/23/2015 15:38:52,false,instagc,1,29411108,USA,OH,Fairfield,71.79.16.89,[CAUSES],[CAUSES],caused by,N/A,69,101,1,88,117,TWrex-cause,810845-FS1,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI
725204474,5/23/2015 13:40:07,1642183500,5/23/2015 13:39:50,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],SVT may respond to drugs such as SOTALOL,n/a,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 13:46:45,1642185476,5/23/2015 13:46:28,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],respond,n/a,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 13:58:02,1642188069,5/23/2015 13:56:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",may respond to,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 13:58:45,1642188296,5/23/2015 13:58:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],SVT may respond to SOTALOL,na,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 13:59:09,1642188323,5/23/2015 13:58:40,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],SVT may respond to SOTALOL,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:07:43,1642190377,5/23/2015 14:07:16,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],may respond to,n,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:30:32,1642196900,5/23/2015 14:29:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],may respond drugs such as SOTALOL,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:31:56,1642197238,5/23/2015 14:31:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],may respond to,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:39:40,1642199195,5/23/2015 14:39:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],may respond to drugs such as,n/a,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:46:07,1642200893,5/23/2015 14:44:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[OTHER],[OTHER],SVT that does not involve the AV node,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:50:41,1642202187,5/23/2015 14:50:19,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drugs or,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:53:40,1642202941,5/23/2015 14:53:25,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],may respond to,N/A,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:53:43,1642202955,5/23/2015 14:53:30,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],does not,-,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:54:31,1642203208,5/23/2015 14:54:10,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],may respond,n/a,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204474,5/23/2015 14:54:43,1642203229,5/23/2015 14:54:08,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],may respond to,n/a,0,89,-1,2,96,TWrex-cause,805021-FS1,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL
725204475,5/23/2015 14:55:48,1642203554,5/23/2015 14:55:36,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],treatment with,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 14:56:57,1642203825,5/23/2015 14:56:41,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 14:57:03,1642203833,5/23/2015 14:56:47,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 14:58:59,1642204409,5/23/2015 14:58:21,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],treatment with,n/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:02:03,1642205101,5/23/2015 15:01:34,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INTERFERON for MULTIPLE SCLEROSIS,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:02:17,1642205193,5/23/2015 15:01:17,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment for,n/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:02:57,1642205329,5/23/2015 15:01:52,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],MULTIPLE SCLEROSIS,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:04:22,1642205742,5/23/2015 15:02:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION] [TREATS],"[TREATS]
[CAUSES]
[MANIFESTATION]",Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,n/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:04:40,1642205836,5/23/2015 15:04:10,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:05:04,1642205899,5/23/2015 15:04:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment with,n/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:07:02,1642206341,5/23/2015 15:06:31,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],natalizumab,NA,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:07:32,1642206399,5/23/2015 15:07:13,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:08:01,1642206508,5/23/2015 15:07:16,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],treatment for,N/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:11:09,1642207496,5/23/2015 15:10:57,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204475,5/23/2015 15:22:41,1642211122,5/23/2015 15:22:23,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,110,87,-1,127,105,TWrex-cause,804212-FS1,Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and INTERFERON BETA 1A for MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A
725204476,5/23/2015 13:31:48,1642181227,5/23/2015 13:31:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],paraINFLUENZA lower respiratory tract INFECTIONS.,n/a,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 13:39:01,1642183091,5/23/2015 13:38:20,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 13:41:42,1642183970,5/23/2015 13:40:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],a suspicion of these respiratory viruses should inform,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 13:44:07,1642184690,5/23/2015 13:43:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],paraINFLUENZA and INFECTIONS.,na,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 13:45:53,1642185247,5/23/2015 13:45:13,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],"influenza, have caused infections;",N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 13:59:55,1642188442,5/23/2015 13:57:29,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],community acquired respiratory viruses,m,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:00:27,1642188592,5/23/2015 13:59:23,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:18:28,1642193265,5/23/2015 14:17:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],suspicion should inform,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:19:20,1642193510,5/23/2015 14:19:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:24:21,1642195002,5/23/2015 14:23:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:30:54,1642196998,5/23/2015 14:30:36,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],respiratory tract,n/a,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:38:05,1642198768,5/23/2015 14:37:38,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [IS_A] [PART_OF],"[CAUSES]
[IS_A]
[PART_OF]",caused a of,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:38:14,1642198802,5/23/2015 14:37:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],all,n/a,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:39:23,1642199157,5/23/2015 14:38:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],have caused,N/A,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204476,5/23/2015 14:48:53,1642201732,5/23/2015 14:46:21,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],have caused,n/a,67,296,1,75,306,TWrex-cause,811145-FS1,"Other community acquired respiratory viruses (e.g., influenza, paraINFLUENZA respiratory syncytial virus, metapneumo virus, and rhinovirus) have caused significant infections; a suspicion of these respiratory viruses should inform the clinical evaluation of all upper and lower respiratory tract INFECTIONS.",INFLUENZA,INFECTIONS
725204477,5/23/2015 14:55:16,1642203361,5/23/2015 14:54:53,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",significantly reduced compared to placebo with INH,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 14:56:05,1642203661,5/23/2015 14:55:41,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],compared,-,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 14:56:24,1642203724,5/23/2015 14:56:10,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],significantly reduced,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 14:57:40,1642203953,5/23/2015 14:57:18,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],significantly reduced with INH,n/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:00:24,1642204755,5/23/2015 14:59:37,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],was significantly reduced,n/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:00:53,1642204829,5/23/2015 15:00:10,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TB reduced INH,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:01:07,1642204856,5/23/2015 15:00:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],placebo,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:01:15,1642204898,5/23/2015 15:00:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",n/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:01:19,1642204917,5/23/2015 15:00:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],incidence reduced,n/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:03:40,1642205613,5/23/2015 15:03:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],reduced,none,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:04:15,1642205720,5/23/2015 15:03:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],significantly reduced with,n/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:05:29,1642206025,5/23/2015 15:05:02,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[TREATS],[TREATS],compared placebo,NA,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:06:38,1642206254,5/23/2015 15:06:16,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:06:47,1642206272,5/23/2015 15:06:14,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],The incidence of active TB was significantly reduced with INH,N/a,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204477,5/23/2015 15:22:01,1642210958,5/23/2015 15:21:37,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],reduced,N/A,24,78,-1,25,81,TWrex-cause,800255-FS1,"The incidence of active TB was significantly reduced compared to placebo with INH (RR, 0.33 [CI, 0.14 to 0.77]) and INH and RIF (RR, 0.4 [CI, 0.18 to 0.86.",TB,INH
725204478,5/23/2015 13:34:20,1642181865,5/23/2015 13:33:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],AUTISM including FRAGILE X SYNDROME,n/a,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 13:40:51,1642183741,5/23/2015 13:40:32,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PART_OF],[PART_OF],including,n/a,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 13:46:06,1642185328,5/23/2015 13:45:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 13:47:43,1642185662,5/23/2015 13:47:19,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with AUTISM including FRAGILE X SYNDROME,na,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 13:48:39,1642185893,5/23/2015 13:48:07,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with AUTISM including FRAGILE X SYNDROME,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:01:45,1642188947,5/23/2015 14:01:30,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:07:50,1642190393,5/23/2015 14:06:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:20:54,1642194047,5/23/2015 14:20:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:23:15,1642194787,5/23/2015 14:22:39,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:28:16,1642196031,5/23/2015 14:27:30,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:32:52,1642197422,5/23/2015 14:32:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:40:10,1642199265,5/23/2015 14:39:38,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:41:19,1642199623,5/23/2015 14:40:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A with,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:43:51,1642200317,5/23/2015 14:43:15,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204478,5/23/2015 14:49:05,1642201795,5/23/2015 14:48:43,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],associated with,-,80,97,1,85,115,TWrex-cause,813207-FS1,"• A review article describes the genetic syndromes consistently associated with AUTISM including FRAGILE X SYNDROME tuberous sclerosis, Angelman syndrome, Prader Willi syndrome, Rett syndrome, Down syndrome, and Turner syndrome ( 50.",AUTISM,FRAGILE X SYNDROME
725204479,5/23/2015 15:41:06,1642216197,5/23/2015 15:40:36,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Biophysical profile A nonstress test fetal breathing movements, PreECLAMPSIA SEIZURES",n/a,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 15:44:00,1642216978,5/23/2015 15:43:22,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",A with an of with of,"A service encounter refers to any interaction where you as a customer interacted with a service employee or a service firm, for instance shopping at a retail store, or dining at a restaurant.  In this survey, our aim is to understand customers' awkward service encounters.  To begin, please take a moment to think of a past service encounter which you would label as awkward.  Try and remember exactly what happened and what it was like being in that encounter.",303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 15:49:37,1642218541,5/23/2015 15:49:15,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[SYMPTOM],[SYMPTOM],SEIZURES,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:10:14,1642224727,5/23/2015 16:09:48,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",A with an a of with of,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:17:52,1642226897,5/23/2015 16:17:38,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:35:38,1642232147,5/23/2015 16:34:53,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",with the presence of,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:44:11,1642234789,5/23/2015 16:43:44,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",with the presence of,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:44:54,1642235051,5/23/2015 16:44:07,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 16:47:30,1642235893,5/23/2015 16:46:20,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Biophysical profile A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being,n/a,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:00:12,1642241091,5/23/2015 16:58:50,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],presence,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:01:53,1642241828,5/23/2015 17:00:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to gauge,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:26:28,1642252619,5/23/2015 17:25:59,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],with the of,n/a,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:33:17,1642256012,5/23/2015 17:32:46,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],with the presence of,n/a,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:34:32,1642256610,5/23/2015 17:33:25,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SIDE_EFFECT],[SIDE_EFFECT],PreECLAMPSIA with presence of SEIZURES,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204479,5/23/2015 17:39:46,1642259060,5/23/2015 17:39:12,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[SYMPTOM],[SYMPTOM],with the presence of,N/A,303,272,1,310,281,TWrex-cause,813728-FS1,"Biophysical profile    A nonstress test combined with an obstetric ultrasound using a total of five components to gauge fetal well being (nonstress test result, amniotic fluid volume, fetal breathing movements, fetal gross body movements, and fetal tone)  Eclampsia    PreECLAMPSIA with the presence of SEIZURES",SEIZURES,ECLAMPSIA
725204480,5/23/2015 15:40:09,1642215999,5/23/2015 15:39:50,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[PART_OF],[PART_OF],INSULIN GLARGINE TYPE 2 DIABETES,n/a,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 15:42:37,1642216619,5/23/2015 15:40:44,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of of of,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 15:48:25,1642218221,5/23/2015 15:47:37,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],TYPE 2 DIABETES,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:09:27,1642224512,5/23/2015 16:09:09,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF],[PART_OF],of of,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:17:20,1642226703,5/23/2015 16:17:10,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[LOCATION] [PREVENTS] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:34:03,1642231672,5/23/2015 16:33:13,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and 2 of insulin detemir in,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:42:30,1642234203,5/23/2015 16:41:34,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,It is not clear if it is a treatment or prevention.,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:43:28,1642234481,5/23/2015 16:41:37,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],insulin detemir,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:45:24,1642235157,5/23/2015 16:44:24,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes,n/a,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:57:53,1642240044,5/23/2015 16:55:02,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],efficacy,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 16:58:51,1642240493,5/23/2015 16:58:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],met efficacy selection criteria:,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 17:25:34,1642252174,5/23/2015 17:22:36,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],efficacy,n/a,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 17:32:14,1642255398,5/23/2015 17:31:32,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],34 RCTs met efficacy selection 9 of INSULIN GLARGINE,n/a,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 17:32:20,1642255438,5/23/2015 17:31:31,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],INSULIN GLARGINE and TYPE 2 DIABETES,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204480,5/23/2015 17:38:48,1642258601,5/23/2015 17:38:08,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[TREATS],[TREATS],of,N/A,172,127,-1,186,143,TWrex-cause,804063-FS1,34 RCTs met efficacy selection criteria: 14 of insulin glargine and 9 of insulin detemir in type 1 diabetes ( n  = 7142); 9 of INSULIN GLARGINE and 2 of insulin detemir in TYPE 2 DIABETES ( n  = 4729.,TYPE 2 DIABETES,INSULIN GLARGINE
725204481,5/23/2015 15:42:16,1642216559,5/23/2015 15:41:59,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[PREVENTS],[PREVENTS],ENOXAPARIN prevention VENOUS THROMBOEMBOLISM,n/a,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 15:50:37,1642218894,5/23/2015 15:50:14,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[PREVENTS],[PREVENTS],VENOUS THROMBOEMBOLISM,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:11:47,1642225096,5/23/2015 16:10:47,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:18:33,1642227135,5/23/2015 16:18:09,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [LOCATION] [SYMPTOM] [NONE],"[PREVENTS]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:37:06,1642232547,5/23/2015 16:36:30,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PREVENTS],[PREVENTS],for prevention of,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:44:51,1642235035,5/23/2015 16:44:36,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS],[PREVENTS],for prevention of,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:45:55,1642235284,5/23/2015 16:45:33,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],prevention of,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 16:54:33,1642238735,5/23/2015 16:53:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement:,n/a,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:01:18,1642241554,5/23/2015 17:00:59,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevention,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:03:07,1642242344,5/23/2015 17:02:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],for prevention of,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:27:42,1642253216,5/23/2015 17:27:30,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PREVENTS],[PREVENTS],for prevention of,n/a,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:35:07,1642256870,5/23/2015 17:34:48,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PREVENTS],[PREVENTS],for prevention of,n/a,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:35:47,1642257142,5/23/2015 17:35:15,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:40:59,1642259589,5/23/2015 17:40:23,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[PREVENTS],[PREVENTS],for prevention of,N/A,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204481,5/23/2015 17:55:44,1642266930,5/23/2015 17:55:18,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],for prevention of VENOUS,n/a,57,28,-1,78,38,TWrex-cause,805032-FS1,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN
725204482,5/23/2015 13:35:16,1642182043,5/23/2015 13:35:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],"RSV, PIV, INFLUENZA VIRUS and some enteroviruses also cause COLDS",n/a,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 13:41:44,1642183974,5/23/2015 13:41:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],cause,n/a,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 13:48:03,1642185721,5/23/2015 13:47:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 13:50:12,1642186213,5/23/2015 13:49:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],INFLUENZA VIRUS cause COLDS,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 13:50:52,1642186392,5/23/2015 13:50:19,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],INFLUENZA VIRUS cause COLDS,na,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:02:51,1642189172,5/23/2015 14:02:34,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],also cause,n,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:12:22,1642191641,5/23/2015 14:10:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:21:41,1642194333,5/23/2015 14:21:26,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:25:25,1642195332,5/23/2015 14:25:00,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:32:32,1642197352,5/23/2015 14:31:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:33:52,1642197657,5/23/2015 14:33:31,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],cause,n/a,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:41:49,1642199835,5/23/2015 14:41:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:42:41,1642200043,5/23/2015 14:42:24,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:46:15,1642200973,5/23/2015 14:45:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204482,5/23/2015 14:49:23,1642201840,5/23/2015 14:49:12,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],also cause,N/A,72,10,1,76,25,TWrex-cause,811030-FS1,"RSV, PIV, INFLUENZA VIRUS adenovirus, and some enteroviruses also cause COLDS",COLDS,INFLUENZA VIRUS
725204483,5/23/2015 13:37:08,1642182576,5/23/2015 13:36:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],alDEMENTIA WITH LEWY BODIES PARKINSONISM,n/a,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 13:43:21,1642184469,5/23/2015 13:42:50,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],present,n/a,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 13:50:30,1642186298,5/23/2015 13:49:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],without,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 13:53:03,1642186686,5/23/2015 13:52:02,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],alDEMENTIA WITH LEWY BODIES may present dementia without PARKINSONISM,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 13:53:30,1642186824,5/23/2015 13:52:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],alDEMENTIA WITH LEWY BODIES PARKINSONISM,na,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:04:10,1642189463,5/23/2015 14:03:44,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may present as,n,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:17:41,1642193040,5/23/2015 14:16:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may present,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:27:26,1642195878,5/23/2015 14:26:50,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[MANIFESTATION],[MANIFESTATION],may present as,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:35:12,1642198039,5/23/2015 14:34:50,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],may present as,n/a,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:37:45,1642198687,5/23/2015 14:36:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may present,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:44:49,1642200551,5/23/2015 14:44:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",without or,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:49:59,1642202005,5/23/2015 14:48:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],may present as,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:50:25,1642202119,5/23/2015 14:49:55,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[MANIFESTATION],[MANIFESTATION],may present as,N/A,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:51:38,1642202380,5/23/2015 14:50:13,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[NONE],[NONE],N/A,Because the lewy bodies can be present without the presence of parkinsonism,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204483,5/23/2015 14:52:33,1642202634,5/23/2015 14:49:53,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,it just says that one can occur without the other,126,36,1,137,61,TWrex-cause,814662-FS1,"Ferman TJ, Boeve BF, Smith GE, et alDEMENTIA WITH LEWY BODIES may present as dementia and REM sleep behavior disorder without PARKINSONISM or hallucinations.",PARKINSONISM,DEMENTIA WITH LEWY BODIES
725204484,5/23/2015 14:54:52,1642203251,5/23/2015 14:54:38,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],ranging from,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 14:55:39,1642203439,5/23/2015 14:55:29,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],cause,-,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 14:56:08,1642203674,5/23/2015 14:55:54,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 14:57:17,1642203900,5/23/2015 14:56:35,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER],[OTHER],digestive disturbance,n/a,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 14:59:35,1642204548,5/23/2015 14:58:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],from to a severe,n/a,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:00:09,1642204717,5/23/2015 14:59:27,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES] [SYMPTOM] [PART_OF],"[CAUSES]
[SYMPTOM]
[PART_OF]",cause digestive disturbance severe FATAL DYSENTERY,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:00:23,1642204748,5/23/2015 14:59:29,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,n/a,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:00:45,1642204809,5/23/2015 14:59:09,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,both are related to Digestive disturbance but not to each other,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:00:49,1642204813,5/23/2015 15:00:20,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],DIARRHEA,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:03:19,1642205462,5/23/2015 15:02:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:03:48,1642205632,5/23/2015 15:03:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,ranges from one to the other,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:05:00,1642205895,5/23/2015 15:04:25,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[SYMPTOM],[SYMPTOM],severe and often,NA,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:06:12,1642206160,5/23/2015 15:05:45,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A] [CAUSES],"[CAUSES]
[IS_A]
[PART_OF]",a of cause,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:06:13,1642206162,5/23/2015 15:05:28,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[PART_OF],[PART_OF],digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,N/a,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204484,5/23/2015 15:21:36,1642210747,5/23/2015 15:20:41,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],ranging,N/A,78,104,1,102,129,TWrex-cause,812880-FS1,It contains a number of species that cause digestive disturbance ranging from MILD DIARRHEA to a severe and often FATAL DYSENTERY,MILD DIARRHEA,FATAL DYSENTERY
725204485,5/23/2015 15:12:08,1642207883,5/23/2015 15:11:25,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CONTRAINDICATES] [ASSOCIATED_WITH],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",STAPHYLOCOCCAL PNEUMONIA STAPHYLOCOCCI,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:14:23,1642208704,5/23/2015 15:13:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],can be identified,n/a,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:14:55,1642208849,5/23/2015 15:14:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],can be identified,none,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:17:02,1642209349,5/23/2015 15:16:32,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],STAPHYLOCOCCAL PNEUMONIA,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:17:04,1642209352,5/23/2015 15:16:43,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [IS_A] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with is of,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:18:44,1642209792,5/23/2015 15:18:08,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CAUSES],[CAUSES],STAPHYLOCOCCI can be identified,N/a,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:34:12,1642214140,5/23/2015 15:33:39,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],identified,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:34:22,1642214179,5/23/2015 15:33:57,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CONTRAINDICATES] [ASSOCIATED_WITH],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",STAPHYLOCOCCAL PNEUMONIA STAPHYLOCOCCI,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:35:04,1642214349,5/23/2015 15:34:36,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [PART_OF] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with is of,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:39:59,1642215941,5/23/2015 15:39:17,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],STAPHYLOCOCCI,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:45:17,1642217297,5/23/2015 15:44:46,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[CAUSES],[CAUSES],STAPHYLOCOCCAL PNEUMONIA STAPHYLOCOCCI,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:50:05,1642218664,5/23/2015 15:48:23,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","purulent sputum production is the rule,",n/a,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 15:52:23,1642219353,5/23/2015 15:50:40,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",can be identified,n/a,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 16:03:37,1642222962,5/23/2015 16:01:44,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [IS_A] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with is of,N/A,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204485,5/23/2015 16:09:12,1642224390,5/23/2015 16:08:26,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,14,134,1,37,147,TWrex-cause,810983-FS1,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI
725204486,5/23/2015 13:37:39,1642182796,5/23/2015 13:37:10,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],RECTAL MESALAMINE treatment of DISTAL ULCERATIVE COLITIS,n/a,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 13:43:37,1642184546,5/23/2015 13:43:21,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 13:51:38,1642186522,5/23/2015 13:50:35,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 13:53:33,1642186827,5/23/2015 13:53:04,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],RECTAL MESALAMINE in treatment of DISTAL ULCERATIVE COLITIS,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 13:53:53,1642186875,5/23/2015 13:53:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],RECTAL MESALAMINE in treatment of DISTAL ULCERATIVE COLITIS,na,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:04:34,1642189575,5/23/2015 14:04:11,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment,n,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:19:45,1642193645,5/23/2015 14:17:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:27:49,1642195947,5/23/2015 14:27:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:35:31,1642198110,5/23/2015 14:35:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],combination therapy in the treatment,n/a,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:38:37,1642198886,5/23/2015 14:37:48,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:45:37,1642200811,5/23/2015 14:44:53,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [TREATS],"[TREATS]
[IS_A]
[PART_OF]",A of treatment of,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:50:27,1642202123,5/23/2015 14:50:15,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:50:31,1642202144,5/23/2015 14:50:00,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:50:46,1642202200,5/23/2015 14:50:26,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],in the treatment of,N/A,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204486,5/23/2015 14:51:49,1642202424,5/23/2015 14:50:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PREVENTS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS,n/a,144,79,-1,168,96,TWrex-cause,800425-FS1,"Safdi M, DeMicco M, Sninsky C, et al. A double blind comparison of oral versus RECTAL MESALAMINE versus combination therapy in the treatment of DISTAL ULCERATIVE COLITIS",DISTAL ULCERATIVE COLITIS,RECTAL MESALAMINE
725204487,5/23/2015 15:13:06,1642208286,5/23/2015 15:12:10,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",EXTRAOCULAR MUSCLE WEAKNESS inflammation extraocular muscles ELECTROMYOGRAPHY TIA,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:14:59,1642208850,5/23/2015 15:14:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most often associated with,n/a,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:15:49,1642208981,5/23/2015 15:14:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],associated with,none,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:17:29,1642209464,5/23/2015 15:17:08,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:17:44,1642209518,5/23/2015 15:17:05,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],MUSCLE WEAKNESS,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:20:25,1642210390,5/23/2015 15:18:47,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most often associated with,N/a,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:34:42,1642214248,5/23/2015 15:34:23,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EXTRAOCULAR MUSCLE WEAKNESS associated Graves hyperthyroidism,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:34:43,1642214263,5/23/2015 15:34:14,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:35:34,1642214510,5/23/2015 15:35:07,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:40:48,1642216133,5/23/2015 15:40:05,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],MULTIPLE SCLEROSIS;,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:46:05,1642217557,5/23/2015 15:45:18,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],EXTRAOCULAR MUSCLE WEAKNESS associated MULTIPLE SCLEROSIS;,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:50:26,1642218821,5/23/2015 15:50:05,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",amyotrophic lateral sclerosis;,n/a,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 15:53:22,1642219728,5/23/2015 15:52:24,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",most often associated with,n/a,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 16:04:08,1642223083,5/23/2015 16:03:40,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with,N/A,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204487,5/23/2015 16:10:00,1642224648,5/23/2015 16:09:15,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,0,264,1,26,306,TWrex-cause,813182-FS1,EXTRAOCULAR MUSCLE WEAKNESS is not fatigable  Due to inflammation in extraocular muscles and orbital connective tissues; most often associated with Graves hyperthyroidism ACh = acetylcholine; AChR = acetylcholine receptor; ALS = amyotrophic lateral sclerosis; EMG = ELECTROMYOGRAPHY MS = MULTIPLE SCLEROSIS; TIA = transient ischemic attack.,EXTRAOCULAR MUSCLE WEAKNESS,MULTIPLE SCLEROSIS
725204488,5/23/2015 13:28:59,1642180379,5/23/2015 13:28:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B + Induction therapy,n/a,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:30:58,1642180992,5/23/2015 13:29:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],who cannot receive,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:32:09,1642181325,5/23/2015 13:31:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Induction therapy,n/a,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:35:03,1642182027,5/23/2015 13:34:35,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],cannot receive,n/a,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:40:03,1642183479,5/23/2015 13:39:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],children with CRYPTOCOCCAL MENINGITIS cannot receive AMPHOTERICIN B,na,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:40:58,1642183785,5/23/2015 13:40:02,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CONTRAINDICATES],[CONTRAINDICATES],CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:50:41,1642186345,5/23/2015 13:49:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 13:53:45,1642186851,5/23/2015 13:53:26,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CONTRAINDICATES],[CONTRAINDICATES],who cannot receive,n,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:13:16,1642191906,5/23/2015 14:11:56,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],cannot receive,NOT VIABLE,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:16:34,1642192737,5/23/2015 14:15:27,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],AMPHOTERICIN B + : Induction therapy,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:17:23,1642192979,5/23/2015 14:17:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:28:29,1642196137,5/23/2015 14:28:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:31:42,1642197175,5/23/2015 14:31:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],cannot receive,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:33:13,1642197515,5/23/2015 14:32:15,false,gifthunterclub,1.0,30901412,GBR,I3,Gillingham,85.210.125.10,[CONTRAINDICATES],[CONTRAINDICATES],CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B,NONE,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204488,5/23/2015 14:34:37,1642197873,5/23/2015 14:33:32,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with with or with or,N/A,52,95,-1,74,109,TWrex-cause,800031-FS1,"427 ,   441  HIV infected infants and children with CRYPTOCOCCAL MENINGITIS who cannot receive AMPHOTERICIN B   +   : Induction therapy with 100 mg/kg daily in 4 divided doses in conjunction with oral or IV fluconazole given for at least 2 weeks, then consolidation therapy with oral or IV fluconazole alone for at least 8 weeks.",CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
725204489,5/23/2015 15:14:18,1642208670,5/23/2015 15:13:37,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM],[SYMPTOM],Patients with PHEOCHROMOCYTOMAS have HEADACHES,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:17:16,1642209408,5/23/2015 15:16:42,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],may have,none,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:18:17,1642209659,5/23/2015 15:15:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",Patients may have,n/a,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:18:21,1642209660,5/23/2015 15:18:05,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with or,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:18:55,1642209886,5/23/2015 15:18:23,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HEADACHES,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:22:01,1642210954,5/23/2015 15:21:40,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[LOCATION],[LOCATION],Patients with may have,N/a,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:35:30,1642214500,5/23/2015 15:35:18,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[LOCATION],[LOCATION],PHEOCHROMOCYTOMAS HEADACHES,n/a,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:35:35,1642214517,5/23/2015 15:35:09,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SIDE_EFFECT],[SIDE_EFFECT],may have,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:36:36,1642214883,5/23/2015 15:36:13,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:42:10,1642216487,5/23/2015 15:41:34,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],HEADACHES,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:48:27,1642218220,5/23/2015 15:48:03,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],PHEOCHROMOCYTOMAS may have HEADACHES,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 15:51:04,1642219104,5/23/2015 15:50:48,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","anxiety, HEADACHES or sweating;",n/a,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 16:05:10,1642223326,5/23/2015 16:04:51,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 16:10:14,1642224732,5/23/2015 16:10:03,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",no,no,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204489,5/23/2015 16:10:14,1642224742,5/23/2015 16:09:47,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],may have,N/A,75,14,1,83,31,TWrex-cause,813187-FS1,"Patients with PHEOCHROMOCYTOMAS may have paroxysmal palpitations, anxiety, HEADACHES or sweating; many are asymptomatic.",HEADACHES,PHEOCHROMOCYTOMAS
725204490,5/23/2015 13:34:39,1642181929,5/23/2015 13:34:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],SEIZURES may be the sole presenting symptom,n/a,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 13:41:12,1642183830,5/23/2015 13:40:52,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],be,n/a,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 13:47:10,1642185563,5/23/2015 13:46:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],may be,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 13:49:22,1642186081,5/23/2015 13:48:40,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[MANIFESTATION],[MANIFESTATION],SEIZURES may be symptom PETIT MAL OR GRAND MAL,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 13:49:30,1642186094,5/23/2015 13:47:45,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],SEIZURES may be PETIT MAL OR GRAND MAL,na,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:02:19,1642189051,5/23/2015 14:01:46,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],and may be,n,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:09:39,1642190914,5/23/2015 14:07:51,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],symptom,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:21:10,1642194156,5/23/2015 14:20:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],symptom,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:24:33,1642195081,5/23/2015 14:23:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],may be,ARE TYPES OF,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:30:38,1642196921,5/23/2015 14:28:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],presenting symptom,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:33:09,1642197471,5/23/2015 14:32:53,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],may be,n/a,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:40:42,1642199372,5/23/2015 14:40:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],may be,n/a,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:41:45,1642199820,5/23/2015 14:41:21,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",symptom OR,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:44:38,1642200533,5/23/2015 14:43:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],symptom,N/A,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204490,5/23/2015 14:49:30,1642201897,5/23/2015 14:48:54,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[MANIFESTATION],[MANIFESTATION],may be,n/a,2,57,1,9,79,TWrex-cause,814310-FS1,SEIZURES may be the sole presenting symptom and may be PETIT MAL OR GRAND MAL focal ( 6 ;  7.,SEIZURES,PETIT MAL GRAND MAL OR
725204491,5/23/2015 13:30:38,1642180864,5/23/2015 13:30:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],HYPEREMESIS GRAVIDARUM PREGNANCY INDUCED VOMITING causes,n/a,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:37:11,1642182623,5/23/2015 13:36:36,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],is,n/a,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:39:07,1642183131,5/23/2015 13:38:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:42:23,1642184149,5/23/2015 13:41:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],HYPEREMESIS GRAVIDARUM is PREGNANCY INDUCED VOMITING,na,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:43:48,1642184613,5/23/2015 13:43:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],Hyperemesis gravidarum is persistent PREGNANCY INDUCED VOMITING,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:55:37,1642187422,5/23/2015 13:55:13,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],is,n,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 13:56:54,1642187801,5/23/2015 13:55:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],is,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:16:35,1642192738,5/23/2015 14:15:29,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],is PREGNANCY INDUCED VOMITING,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:18:28,1642193267,5/23/2015 14:18:09,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causes,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:20:56,1642194101,5/23/2015 14:19:59,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],is persistent PREGNANCY INDUCED VOMITING,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:29:58,1642196681,5/23/2015 14:29:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],is,n/a,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:35:50,1642198223,5/23/2015 14:34:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],is persistent,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:36:36,1642198462,5/23/2015 14:36:10,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is or,N/A,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:36:38,1642198471,5/23/2015 14:36:25,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],is,n/a,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204491,5/23/2015 14:46:19,1642200979,5/23/2015 14:44:28,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],is persistent,n/a,68,29,1,93,51,TWrex-cause,814795-FS1,"Hyperemesis gravidarum (see  HYPEREMESIS GRAVIDARUM ) is persistent PREGNANCY INDUCED VOMITING that causes significant dehydration, often with electrolyte abnormalities or ketosis.",PREGNANCY INDUCED VOMITING,HYPEREMESIS GRAVIDARUM
725204492,5/23/2015 15:43:38,1642216846,5/23/2015 15:43:02,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",INTRAVASCULAR HEMOLYSIS infection COLD AGGLUTININ DISEASE,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 15:52:36,1642219417,5/23/2015 15:52:05,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[SYMPTOM],[SYMPTOM],COLD AGGLUTININ DISEASE,N/A,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 16:13:09,1642225452,5/23/2015 16:12:46,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is is with,N/A,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 16:39:12,1642233089,5/23/2015 16:38:39,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",characterized by numerous,N/A,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 16:46:11,1642235382,5/23/2015 16:45:28,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No immediate relation.,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 16:49:28,1642236684,5/23/2015 16:46:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[NONE],[NONE],N/A,Intravascular hemolysis is a characteristic of paroxysmal cold hemoglobinuria.,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 16:56:30,1642239539,5/23/2015 16:55:51,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Paroxysmal cold hemoglobinuria characterized INTRAVASCULAR HEMOLYSIS often following infection Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear;,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:05:17,1642243141,5/23/2015 17:04:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,N/A,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:11:51,1642245783,5/23/2015 17:09:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is seen on,N/A,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:29:01,1642253833,5/23/2015 17:28:40,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],characterized by,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:36:28,1642257461,5/23/2015 17:35:58,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],often characterized by numerous spherocytes on blood smear;,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:37:33,1642257945,5/23/2015 17:36:47,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],INTRAVASCULAR HEMOLYSIS on smear with COLD AGGLUTININ DISEASE,N/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:43:28,1642260699,5/23/2015 17:41:59,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[NONE],[NONE],N/A,seem to be two seperate things,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 17:59:50,1642269038,5/23/2015 17:58:16,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is seen on smear with COLD,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204492,5/23/2015 18:29:57,1642284253,5/23/2015 18:29:20,false,clixsense,1,22947672,GBR,"","",88.144.127.68,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",INTRAVASCULAR HEMOLYSIS seen on smear with COLD AGGLUTININ DISEASE,n/a,62,254,1,84,277,TWrex-cause,813068-FS1,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE
725204493,5/23/2015 14:57:17,1642203901,5/23/2015 14:57:02,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[LOCATION],[LOCATION],lung diseases,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 14:58:53,1642204368,5/23/2015 14:58:09,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],diseases,-,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:02:06,1642205134,5/23/2015 15:01:33,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],LUNG and LUNG DISEASES,/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:05:34,1642206049,5/23/2015 15:05:07,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PART_OF],[PART_OF],LUNG interstitial LUNG DISEASES,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:07:30,1642206389,5/23/2015 15:06:13,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may affect the and,n/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:07:32,1642206406,5/23/2015 15:06:44,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],term,none,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:08:09,1642206539,5/23/2015 15:07:20,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],LUNG DISEASES,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:08:21,1642206613,5/23/2015 15:07:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],lung disease,n/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:09:50,1642207057,5/23/2015 15:09:10,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[PART_OF],[PART_OF],is often preferred.,NA,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:10:35,1642207308,5/23/2015 15:10:08,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:10:46,1642207355,5/23/2015 15:09:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]","Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",n/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:11:24,1642207594,5/23/2015 15:10:01,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[LOCATION],[LOCATION],and interstitial LUNG DISEASES,N/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:21:08,1642210612,5/23/2015 15:20:49,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[LOCATION],[LOCATION],of LUNG,n/a,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:24:34,1642211773,5/23/2015 15:23:51,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],affect,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204493,5/23/2015 15:26:28,1642212342,5/23/2015 15:25:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of is,N/A,88,110,-1,91,123,TWrex-cause,802333-FS1,"Because airways disease and other lung diseases also may affect the interstitium of the LUNG and interstitial LUNG DISEASES can affect the airways, the term diffuse parenchymal lung disease (DPLD) is often preferred.",LUNG,LUNG DISEASES
725204494,5/23/2015 15:09:24,1642206967,5/23/2015 15:09:03,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM],[SYMPTOM],FIBROMYALGIA SYNDROME future) PAIN,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:10:39,1642207321,5/23/2015 15:09:49,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],indicated for,none,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:11:09,1642207497,5/23/2015 15:10:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicated for diabetic neuropathy,n/a,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:14:27,1642208712,5/23/2015 15:12:35,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FIBROMYALGIA SYNDROME,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:15:11,1642208864,5/23/2015 15:14:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],(and,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:16:38,1642209225,5/23/2015 15:15:49,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[NONE],[NONE],N/a,No relation between terms,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:17:40,1642209504,5/23/2015 15:16:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]",Duloxetine (Cymbalta 60 mg/d Approximately 20% 30% better than placebo Elevated blood pressure Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,n/a,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:23:49,1642211500,5/23/2015 15:22:21,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],indicated,-,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:32:02,1642213601,5/23/2015 15:31:38,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],pressure,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:32:19,1642213638,5/23/2015 15:31:51,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:32:21,1642213647,5/23/2015 15:31:53,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",Duloxetine Elevated blood pressure FIBROMYALGIA SYNDROME PAIN,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:37:08,1642215081,5/23/2015 15:36:33,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],PAIN,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:40:19,1642216031,5/23/2015 15:39:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",(and possibly,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:42:56,1642216669,5/23/2015 15:42:12,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[CAUSES],[CAUSES],FIBROMYALGIA SYNDROME PAIN,N/A,191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204494,5/23/2015 15:46:45,1642217765,5/23/2015 15:44:59,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"From this para, I would say that the word PAIN is NOt related, or part of the next sentence. I makes no sence wehen readin gthis",191,154,1,194,175,TWrex-cause,813983-FS1,Duloxetine (Cymbalta    60 mg/d  Approximately 20% 30% better than placebo  Elevated blood pressure  Only indicated for diabetic neuropathy (and possibly FIBROMYALGIA SYNDROME in the future) PAIN,PAIN,FIBROMYALGIA SYNDROME
725204495,5/23/2015 15:25:39,1642212163,5/23/2015 15:24:57,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[LOCATION] [IS_A],"[LOCATION]
[IS_A]",INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES,N/a,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 15:38:04,1642215352,5/23/2015 15:37:41,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SIDE_EFFECT],[SIDE_EFFECT],"INTERSTITIUM OF THE LUNG LUNG DISEASES affect airways,",n/a,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 15:38:17,1642215412,5/23/2015 15:37:55,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],and,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 15:39:20,1642215785,5/23/2015 15:38:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 15:45:48,1642217453,5/23/2015 15:45:18,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LUNG DISEASES,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:07:42,1642224016,5/23/2015 16:07:15,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",OF is,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:13:49,1642225748,5/23/2015 16:13:09,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],may affect,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:15:21,1642226172,5/23/2015 16:14:41,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:31:21,1642230831,5/23/2015 16:30:41,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",and interstitial,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:39:19,1642233183,5/23/2015 16:38:16,false,coinworker,1.0,20231698,USA,GA,"",172.56.0.166,[PART_OF] [MANIFESTATION],"[MANIFESTATION]
[PART_OF]","may affect can affect the airways,",N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:39:22,1642233195,5/23/2015 16:38:17,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",may affect the,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:40:02,1642233423,5/23/2015 16:39:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[LOCATION],[LOCATION],may affect,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:42:12,1642234119,5/23/2015 16:41:35,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways,",n/a,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:51:11,1642237295,5/23/2015 16:51:02,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],(DPLD),n/a,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204495,5/23/2015 16:54:42,1642238758,5/23/2015 16:53:02,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[LOCATION],[LOCATION],may affect the,N/A,67,109,-1,90,122,TWrex-cause,802334-FS1,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES
725204496,5/23/2015 15:42:40,1642216639,5/23/2015 15:42:17,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],BOTULINUM ANTITOXIN BOTULISM biologic warfare bioterrorism.,n/a,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 15:51:14,1642219144,5/23/2015 15:50:40,false,neodev,1,32087449,GBR,"","",88.150.208.29,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BOTULISM,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:12:19,1642225270,5/23/2015 16:11:51,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:18:47,1642227230,5/23/2015 16:18:35,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:37:47,1642232698,5/23/2015 16:37:12,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [PART_OF] [CONTRAINDICATES],"[CONTRAINDICATES]
[ASSOCIATED_WITH]
[PART_OF]",may be indicated for,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:45:14,1642235129,5/23/2015 16:44:51,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],may be indicated for,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:46:22,1642235473,5/23/2015 16:45:56,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],indicated for,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 16:55:08,1642238893,5/23/2015 16:54:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,n/a,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:03:48,1642242625,5/23/2015 17:03:08,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],also may be indicated for,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:06:14,1642243555,5/23/2015 17:04:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],may be indicated,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:28:00,1642253359,5/23/2015 17:27:43,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],may be indicated for,n/a,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:35:41,1642257089,5/23/2015 17:35:08,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may be indicated for BOTULISM,n/a,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:36:20,1642257424,5/23/2015 17:35:48,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],BOTULINUM ANTITOXIN may be indicated for BOTULISM,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:41:39,1642259940,5/23/2015 17:41:01,false,neodev,1,14861092,GBR,H3,Leeds,176.252.95.131,[TREATS],[TREATS],may be indicated for,N/A,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204496,5/23/2015 17:57:46,1642267955,5/23/2015 17:55:46,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also may be indicated for BOTULISM,n/a,46,0,1,53,19,TWrex-cause,812256-FS1,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN
725204497,5/23/2015 15:43:01,1642216681,5/23/2015 15:42:41,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],TOXOPLASMOSIS caused TOXOPLASMA GONDII,n/a,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 15:52:01,1642219258,5/23/2015 15:51:18,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],TOXOPLASMA GONDII,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:12:42,1642225354,5/23/2015 16:12:22,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",of caused by with,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:18:58,1642227270,5/23/2015 16:18:49,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:38:28,1642232915,5/23/2015 16:37:51,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CAUSES],[CAUSES],caused by,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:45:27,1642235172,5/23/2015 16:45:15,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],caused by,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:46:44,1642235608,5/23/2015 16:46:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 16:55:50,1642239281,5/23/2015 16:55:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],Toxoplasmosis Prevention of TOXOPLASMOSIS caused by TOXOPLASMA GONDII,n/a,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:04:10,1642242754,5/23/2015 17:03:50,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:06:33,1642243754,5/23/2015 17:06:15,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:28:39,1642253715,5/23/2015 17:28:01,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],caused by,n/a,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:35:57,1642257247,5/23/2015 17:35:42,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES],[CAUSES],caused by,n/a,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:36:46,1642257594,5/23/2015 17:36:21,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],TOXOPLASMOSIS caused by TOXOPLASMA GONDII,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:41:58,1642260065,5/23/2015 17:41:40,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[CAUSES],[CAUSES],caused by,N/A,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204497,5/23/2015 17:58:15,1642268219,5/23/2015 17:57:47,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],caused by TOXOPLASMA,n/a,34,59,1,46,76,TWrex-cause,810355-FS1,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII
725204498,5/23/2015 14:57:33,1642203935,5/23/2015 14:57:18,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[LOCATION],[LOCATION],growth in the,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 14:59:16,1642204485,5/23/2015 14:58:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],called,-,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:02:27,1642205226,5/23/2015 15:02:07,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],abnormal growth in,n/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:06:16,1642206166,5/23/2015 15:05:34,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BRAIN called HYPOTHALAMIC HAMARTOMA characteristic,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:08:11,1642206554,5/23/2015 15:07:31,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[LOCATION],[LOCATION],in the,n/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:08:10,1642206555,5/23/2015 15:07:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],characteristic,none,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:08:29,1642206676,5/23/2015 15:08:10,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],BRAIN,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:08:44,1642206718,5/23/2015 15:08:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],in the,n/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:10:20,1642207247,5/23/2015 15:09:51,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[PART_OF],[PART_OF],growth called,NA,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:11:18,1642207556,5/23/2015 15:11:00,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",An a is of,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:11:36,1642207680,5/23/2015 15:10:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [LOCATION],"[LOCATION]
[MANIFESTATION]",An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,n/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:11:57,1642207823,5/23/2015 15:11:25,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[LOCATION],[LOCATION],An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA,N/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:21:20,1642210667,5/23/2015 15:21:09,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[LOCATION],[LOCATION],in the,n/a,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:24:54,1642211860,5/23/2015 15:24:36,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],growth,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204498,5/23/2015 15:30:00,1642213005,5/23/2015 15:29:20,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",abnormal growth BRAIN HYPOTHALAMIC HAMARTOMA,N/A,26,41,-1,30,63,TWrex-cause,802459-FS1,An abnormal growth in the BRAIN called a HYPOTHALAMIC HAMARTOMA is characteristic of this disorder.,BRAIN,HYPOTHALAMIC HAMARTOMA
725204499,5/23/2015 14:56:14,1642203694,5/23/2015 14:55:49,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],when treated with,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 14:57:17,1642203902,5/23/2015 14:57:04,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],including,-,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 14:57:16,1642203903,5/23/2015 14:56:59,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 14:59:31,1642204524,5/23/2015 14:59:01,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],treated with,n/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:02:54,1642205327,5/23/2015 15:02:17,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],including,n/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:02:55,1642205328,5/23/2015 15:02:04,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],treated PAH including BOSENTAN,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:04:12,1642205713,5/23/2015 15:02:59,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],PVOD,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:05:24,1642206013,5/23/2015 15:04:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]","Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",n/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:05:24,1642206018,5/23/2015 15:04:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treated,none,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:05:31,1642206035,5/23/2015 15:05:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],when treated with,n/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:07:33,1642206407,5/23/2015 15:07:03,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],agents used,NA,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:08:06,1642206520,5/23/2015 15:07:35,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treated with,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:08:34,1642206706,5/23/2015 15:08:02,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CAUSES],[CAUSES],when treated with,N/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:12:14,1642207913,5/23/2015 15:11:10,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treated,n/a,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204499,5/23/2015 15:24:54,1642211858,5/23/2015 15:22:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treated with,N/A,114,145,-1,116,153,TWrex-cause,800317-FS1,"Specifically, pulmonary edema has been reported to develop in patients with PVOD when treated with agents used in PAH including epoprostenol and BOSENTAN",PAH,BOSENTAN
725204500,5/23/2015 14:58:08,1642204095,5/23/2015 14:57:50,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[IS_A],[IS_A],CMV,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 14:59:41,1642204586,5/23/2015 14:59:29,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],cause,-,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:03:38,1642205597,5/23/2015 15:02:47,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[MANIFESTATION],[MANIFESTATION],develops in,n/a,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:07:25,1642206385,5/23/2015 15:06:55,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],CMV INFECTION CMV cause,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:08:59,1642206806,5/23/2015 15:08:39,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:09:28,1642206971,5/23/2015 15:09:02,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],CMV INFECTION,n/a,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:11:01,1642207443,5/23/2015 15:09:24,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],CMV INFECTION,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:13:37,1642208463,5/23/2015 15:13:10,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",or is cause,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:13:39,1642208471,5/23/2015 15:13:16,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[IS_A],[IS_A],CMV INFECTION,N/a,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:14:08,1642208617,5/23/2015 15:13:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]","More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",n/a,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:30:36,1642213259,5/23/2015 15:30:17,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],cause,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:30:51,1642213313,5/23/2015 15:30:09,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",or is cause of,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:31:04,1642213359,5/23/2015 15:30:40,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],CMV INFECTION multiple blood transfusions transplantation; cause,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:34:58,1642214308,5/23/2015 15:33:50,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],CMV,na,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204500,5/23/2015 15:41:17,1642216207,5/23/2015 15:40:31,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[PART_OF],[PART_OF],CMV INFECTION CMV,N/A,17,17,1,29,20,TWrex-cause,810757-FS1,"More frequently, CMV INFECTION develops in patients who have received multiple blood transfusions or who have undergone organ transplantation; CMV is the cause of 50% of all febrile episodes in renal transplant recipients.",CMV INFECTION,CMV
725204501,5/23/2015 13:36:38,1642182439,5/23/2015 13:36:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],treatment DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,n/a,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 13:42:49,1642184297,5/23/2015 13:42:21,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 13:49:43,1642186121,5/23/2015 13:49:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 13:52:00,1642186588,5/23/2015 13:51:37,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 13:52:47,1642186670,5/23/2015 13:51:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,na,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:03:43,1642189316,5/23/2015 14:03:28,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:16:29,1642192723,5/23/2015 14:15:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:22:34,1642194646,5/23/2015 14:22:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:26:49,1642195700,5/23/2015 14:26:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:34:49,1642197975,5/23/2015 14:34:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:36:40,1642198473,5/23/2015 14:34:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:44:21,1642200437,5/23/2015 14:43:51,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by or of,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:48:55,1642201740,5/23/2015 14:48:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:49:52,1642201995,5/23/2015 14:49:31,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204501,5/23/2015 14:49:54,1642202002,5/23/2015 14:49:35,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811209-FS1,"106 ,   107 ,   127  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to ethionamide when isoniazid and/or rifampin cannot be used because of resistance and/or intolerance.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725204502,5/23/2015 15:14:44,1642208777,5/23/2015 15:14:19,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",HCV ASSOCIATED CRYOGLOBULINEMIA respond to INTERFERON ALFA THERAPY,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:17:53,1642209586,5/23/2015 15:17:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treated,none,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:18:33,1642209729,5/23/2015 15:18:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],failed to respond to,n/a,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:19:01,1642209919,5/23/2015 15:18:29,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treated with,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:19:26,1642210139,5/23/2015 15:18:57,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],ASSOCIATED CRYOGLOBULINEMIA,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:23:01,1642211215,5/23/2015 15:22:02,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CONTRAINDICATES],[CONTRAINDICATES],who had failed to respond to,N/a,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:36:03,1642214667,5/23/2015 15:35:32,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[TREATS],[TREATS],HCV ASSOCIATED CRYOGLOBULINEMIA INTERFERON ALFA THERAPY treated,n/a,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:36:09,1642214705,5/23/2015 15:35:36,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],THERAPY,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:37:04,1642215045,5/23/2015 15:36:39,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treated,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:42:39,1642216627,5/23/2015 15:42:13,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],INTERFERON ALFA THERAPY,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:48:52,1642218329,5/23/2015 15:48:27,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],HCV ASSOCIATED CRYOGLOBULINEMIA failed to respond INTERFERON ALFA THERAPY,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 15:51:27,1642219188,5/23/2015 15:51:06,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",HCV ASSOCIATED CRYOGLOBULINEMIA who,n/a,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 16:05:38,1642223432,5/23/2015 16:05:14,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treated,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 16:10:28,1642224774,5/23/2015 16:10:17,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204502,5/23/2015 16:10:55,1642224861,5/23/2015 16:10:16,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],who had failed to respond to,N/A,54,115,-1,84,138,TWrex-cause,803707-FS1,"Evidence: • In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY
725204503,5/23/2015 13:36:19,1642182333,5/23/2015 13:35:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],treatment with FLUDARABINE CYCLOPHOSPHAMIDE RITUIXMAB(FCR) improves overall survival patients with LEUKEMIA,n/a,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 13:42:19,1642184104,5/23/2015 13:42:02,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,question,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 13:49:19,1642186072,5/23/2015 13:48:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],improves overall survival,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 13:51:37,1642186519,5/23/2015 13:50:44,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],"treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C AND RITUIXMAB(FCR) with LEUKEMIA (CLL):",N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 13:51:57,1642186579,5/23/2015 13:51:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],"treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C AND RITUIXMAB(FCR) in patients with LEUKEMIA (CLL):",na,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:03:27,1642189238,5/23/2015 14:03:08,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment with,n,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:15:23,1642192445,5/23/2015 14:13:49,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:22:23,1642194598,5/23/2015 14:21:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],improves overall survival,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:26:31,1642195614,5/23/2015 14:25:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],improves overall survival,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:34:14,1642197739,5/23/2015 14:33:14,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],improves overall survival (OS) in previously untreated patients,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:34:31,1642197862,5/23/2015 14:34:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment with,n/a,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:43:48,1642200292,5/23/2015 14:43:09,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]","A, with with of an",N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:44:23,1642200466,5/23/2015 14:42:02,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],previously untreated,n/a,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:48:09,1642201524,5/23/2015 14:46:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],improves overall survival,N/A,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204503,5/23/2015 14:50:42,1642202181,5/23/2015 14:49:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL):",n/a,233,70,-1,246,118,TWrex-cause,803829-FS1,"Hallek M, Fingerle Rowson G, Fink A, et al. First line treatment with FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB(FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic LEUKEMIA (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group [abstract.",LEUKEMIA (CLL),"FLUDARABINE (F), CYCLOPHOSPHAMIDE (C ), AND RITUIXMAB"
725204504,5/23/2015 15:11:23,1642207593,5/23/2015 15:10:55,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],treatment of SEVERE HYPERTENSION PROPRANOLOL,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:13:49,1642208502,5/23/2015 15:13:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of comparison with,n/a,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:14:02,1642208597,5/23/2015 15:13:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:16:30,1642209186,5/23/2015 15:15:44,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],SEVERE HYPERTENSION,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:16:40,1642209227,5/23/2015 15:16:10,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with with,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:18:06,1642209610,5/23/2015 15:17:39,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],treatment of with,N/a,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:33:38,1642214016,5/23/2015 15:33:20,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:33:56,1642214061,5/23/2015 15:33:23,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SIDE_EFFECT] [TREATS],"[TREATS]
[SIDE_EFFECT]","Effect blood pressure, treatment SEVERE HYPERTENSION PROPRANOLOL",N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:34:33,1642214214,5/23/2015 15:33:58,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with with,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:39:10,1642215721,5/23/2015 15:38:38,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],PROPRANOLOL,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:44:45,1642217204,5/23/2015 15:44:07,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],treatment SEVERE HYPERTENSION PROPRANOLOL,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:48:22,1642218213,5/23/2015 15:47:52,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",and aldosterone concentrations during treatment,n/a,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 15:50:38,1642218922,5/23/2015 15:48:47,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],during treatment with,n/a,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 16:01:40,1642222294,5/23/2015 16:01:17,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with with,N/A,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204504,5/23/2015 16:08:23,1642224171,5/23/2015 16:07:53,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,128,192,-1,146,203,TWrex-cause,800167-FS1,"Trust PM, Rosei EA, Brown JJ et al. Effect of blood pressure, angiotensin II and aldosterone concentrations during treatment of SEVERE HYPERTENSION with intravenous labetalol: comparison with PROPRANOLOL",SEVERE HYPERTENSION,PROPRANOLOL
725204505,5/23/2015 13:31:28,1642181170,5/23/2015 13:30:53,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alCEFPROZIL focus on BRONCHITIS,na,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:38:20,1642182929,5/23/2015 13:37:30,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],focus on,n/a,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:40:44,1642183721,5/23/2015 13:39:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],vs. cefuroxime axetil in,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:43:28,1642184507,5/23/2015 13:42:46,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alCEFPROZIL in mild BRONCHITIS,na,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:45:12,1642185102,5/23/2015 13:44:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],alCEFPROZIL BRONCHITIS,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:57:28,1642187954,5/23/2015 13:56:09,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],focus on,n,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 13:59:21,1642188341,5/23/2015 13:58:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],in mild to moderate lower respiratory tract infections:,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:17:50,1642193071,5/23/2015 14:16:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],vs. cefuroxime in respiratory tract infections:,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:19:04,1642193419,5/23/2015 14:18:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:23:15,1642194788,5/23/2015 14:21:54,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:30:35,1642196913,5/23/2015 14:30:15,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],in,n/a,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:37:34,1642198677,5/23/2015 14:37:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:37:50,1642198749,5/23/2015 14:37:13,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],in,n/a,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:38:41,1642198900,5/23/2015 14:37:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],vs. cefuroxime axetil in mild to moderate,N/A,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204505,5/23/2015 14:47:14,1642201241,5/23/2015 14:46:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS,n/a,136,37,-1,145,46,TWrex-cause,803678-FS1,"Bonnet JP, Ginsberg D, Nolen TM et alCEFPROZIL vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: a focus on BRONCHITIS",BRONCHITIS,CEFPROZIL
725204506,5/23/2015 15:15:16,1642208877,5/23/2015 15:14:45,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",symptoms CLUSTER HEADACHE TRIGEMINAL AUTONOMIC HEADACHES,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:18:33,1642209733,5/23/2015 15:17:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],symptoms,none,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:19:21,1642210116,5/23/2015 15:19:04,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM],[SYMPTOM],symptoms,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:19:29,1642210184,5/23/2015 15:18:34,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different types of headaches,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:19:46,1642210243,5/23/2015 15:19:28,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],CLUSTER HEADACHE,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:23:29,1642211371,5/23/2015 15:23:03,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[IS_A],[IS_A],from migraine and other,N/a,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:36:19,1642214751,5/23/2015 15:36:04,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SYMPTOM],[SYMPTOM],distinguish CLUSTER HEADACHE migraine TRIGEMINAL AUTONOMIC,n/a,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:36:31,1642214851,5/23/2015 15:36:10,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],other,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:37:28,1642215187,5/23/2015 15:37:08,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SYMPTOM],[SYMPTOM],symptoms,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:43:15,1642216747,5/23/2015 15:42:42,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[SYMPTOM],[SYMPTOM],TRIGEMINAL AUTONOMIC HEADACHES,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:49:31,1642218527,5/23/2015 15:48:53,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CLUSTER HEADACHE from migraine TRIGEMINAL AUTONOMIC HEADACHES,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 15:51:37,1642219216,5/23/2015 15:51:28,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Evaluate symptoms to distinguish,n/a,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 16:05:56,1642223523,5/23/2015 16:05:42,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[SYMPTOM],[SYMPTOM],symptoms,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 16:11:08,1642224886,5/23/2015 16:10:32,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204506,5/23/2015 16:11:32,1642224952,5/23/2015 16:10:57,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",distinguish from other,N/A,116,51,1,145,109,TWrex-cause,813917-FS1,C]  History and Physical Examination  3.1 Evaluate symptoms to distinguish CLUSTER HEADACHE from migraine and other TRIGEMINAL AUTONOMIC HEADACHES,TRIGEMINAL AUTONOMIC HEADACHES,CLUSTER HEADACHE
725204507,5/23/2015 14:54:37,1642203219,5/23/2015 14:54:25,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],commonly causes,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:55:27,1642203409,5/23/2015 14:55:11,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],causes,-,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:55:52,1642203602,5/23/2015 14:55:37,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causes,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:56:33,1642203784,5/23/2015 14:56:13,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],commonly causes,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:58:48,1642204324,5/23/2015 14:57:48,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],commonly causes,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:58:52,1642204367,5/23/2015 14:57:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],causes,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:59:08,1642204471,5/23/2015 14:58:41,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],causes,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:59:24,1642204502,5/23/2015 14:58:31,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES] [MANIFESTATION] [PART_OF],"[CAUSES]
[MANIFESTATION]
[PART_OF]",causes CYCLIC MENSTRUAL PAIN,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 14:59:28,1642204518,5/23/2015 14:57:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:00:18,1642204732,5/23/2015 14:59:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],uterus,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:02:51,1642205323,5/23/2015 15:01:57,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causes,none,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:03:16,1642205442,5/23/2015 15:02:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],commonly causes,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:04:24,1642205753,5/23/2015 15:03:31,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly causes,n/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:05:26,1642206024,5/23/2015 15:05:09,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CAUSES],[CAUSES],commonly causes,N/a,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204507,5/23/2015 15:05:36,1642206060,5/23/2015 15:05:00,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,256,162,1,283,173,TWrex-cause,812708-FS1,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS
725204508,5/23/2015 13:28:40,1642180292,5/23/2015 13:28:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alCLOZAPINE in the treatment of patients with DOPAMINOMIMETIC PSYCHOSIS,n/a,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:29:38,1642180562,5/23/2015 13:28:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:31:54,1642181240,5/23/2015 13:31:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:34:34,1642181927,5/23/2015 13:34:14,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:39:29,1642183346,5/23/2015 13:38:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alCLOZAPINE in treatment of patients with DOPAMINOMIMETIC PSYCHOSIS,na,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:40:01,1642183464,5/23/2015 13:39:28,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],alCLOZAPINE in treatment with DOPAMINOMIMETIC PSYCHOSIS,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:49:03,1642185967,5/23/2015 13:47:41,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 13:53:25,1642186821,5/23/2015 13:53:01,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],the treatment of,n,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:11:55,1642191493,5/23/2015 14:11:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:15:22,1642192437,5/23/2015 14:14:01,false,neodev,1,20233773,NLD,"","",37.139.31.195,[TREATS],[TREATS],alCLOZAPINE in the treatment DOPAMINOMIMETIC PSYCHOSIS,alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:15:25,1642192442,5/23/2015 14:14:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:17:06,1642192901,5/23/2015 14:16:52,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:17:15,1642192957,5/23/2015 14:17:06,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:28:13,1642196025,5/23/2015 14:27:57,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204508,5/23/2015 14:31:19,1642197095,5/23/2015 14:29:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,92,35,-1,116,44,TWrex-cause,803562-FS1,"Wolters EC, Hurwitz TA, Mak E et alCLOZAPINE in the treatment of parkinsonian patients with DOPAMINOMIMETIC PSYCHOSIS",DOPAMINOMIMETIC PSYCHOSIS,CLOZAPINE
725204509,5/23/2015 14:54:25,1642203174,5/23/2015 14:54:11,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[PART_OF],[PART_OF],and associated,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:55:09,1642203327,5/23/2015 14:54:45,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,-,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:55:36,1642203435,5/23/2015 14:55:20,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],condition,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:56:12,1642203687,5/23/2015 14:55:41,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[MANIFESTATION],[MANIFESTATION],associated,n/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:57:43,1642203976,5/23/2015 14:56:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,n/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:57:46,1642203993,5/23/2015 14:56:39,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],which is an,n/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:57:55,1642204054,5/23/2015 14:56:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS] [ASSOCIATED_WITH],"[PREVENTS]
[ASSOCIATED_WITH]",associated,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:58:30,1642204245,5/23/2015 14:57:28,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[PART_OF]",associated NEUTROPHILIA,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:58:40,1642204273,5/23/2015 14:58:11,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:59:48,1642204601,5/23/2015 14:58:22,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],SWEET SYNDROME,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 14:59:50,1642204616,5/23/2015 14:59:05,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH] [PART_OF] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is is an with of cause.,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 15:01:57,1642205096,5/23/2015 15:01:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],associated,none,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 15:02:54,1642205325,5/23/2015 15:02:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and associated,n/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 15:03:30,1642205563,5/23/2015 15:02:25,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[SYMPTOM],[SYMPTOM],painful cutaneous plaques,N/A,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204509,5/23/2015 15:05:08,1642205928,5/23/2015 15:04:43,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and associated,N/a,137,42,1,148,56,TWrex-cause,813001-FS1,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME
725204510,5/23/2015 13:29:57,1642180640,5/23/2015 13:29:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM,n/a,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:32:42,1642181441,5/23/2015 13:32:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevention of,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:35:47,1642182189,5/23/2015 13:35:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],prevention,n/a,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:41:09,1642183824,5/23/2015 13:40:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM,na,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:41:48,1642183998,5/23/2015 13:41:25,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:54:04,1642186969,5/23/2015 13:52:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prevention,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 13:54:34,1642187152,5/23/2015 13:54:17,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],for the prevention of,n,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:13:57,1642192030,5/23/2015 14:13:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:17:51,1642193074,5/23/2015 14:17:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevention,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:18:12,1642193178,5/23/2015 14:17:15,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],for the prevention,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:29:02,1642196399,5/23/2015 14:28:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],for the prevention of,n/a,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:32:46,1642197391,5/23/2015 14:32:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention of,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:35:28,1642198085,5/23/2015 14:35:05,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:35:59,1642198273,5/23/2015 14:35:44,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204510,5/23/2015 14:43:50,1642200307,5/23/2015 14:42:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,n/a,76,30,-1,97,53,TWrex-cause,804896-FS1,Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
725204511,5/23/2015 13:28:20,1642180235,5/23/2015 13:28:04,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CONVENTIONAL AMPHOTERICIN B in HIV infected adults,n/a,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:28:22,1642180236,5/23/2015 13:27:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],in,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:31:40,1642181188,5/23/2015 13:31:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],0.7 1 mg/kg daily.,n/a,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:34:13,1642181827,5/23/2015 13:33:27,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:38:46,1642183042,5/23/2015 13:37:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONVENTIONAL AMPHOTERICIN B or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,na,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:39:27,1642183328,5/23/2015 13:38:20,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONVENTIONAL AMPHOTERICIN B with EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:47:35,1642185641,5/23/2015 13:45:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in HIV infected adults with,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:53:00,1642186681,5/23/2015 13:52:17,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],with diffuse,n,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 13:53:58,1642186936,5/23/2015 13:53:00,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],HIV infected adults with,n/a,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:11:35,1642191412,5/23/2015 14:10:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],0.7 1 mg/kg,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:13:59,1642192048,5/23/2015 14:11:59,false,neodev,1.0,20233773,NLD,"","",37.139.31.195,[TREATS],[TREATS],AMPHOTERICIN B in HIV infected adults,AMPHOTERICIN B in HIV infected adults,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:14:47,1642192262,5/23/2015 14:13:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS:,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:16:51,1642192825,5/23/2015 14:16:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],infected,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:17:04,1642192897,5/23/2015 14:16:32,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],in,n/a,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204511,5/23/2015 14:29:18,1642196481,5/23/2015 14:27:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],1 mg/kg daily.,N/A,114,37,-1,158,64,TWrex-cause,800971-FS1,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B
725204512,5/23/2015 13:39:34,1642183355,5/23/2015 13:39:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],(EMPHYSEMA) in the more radiolucent regions of the LUNG,n/a,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 13:45:55,1642185269,5/23/2015 13:45:14,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],regions,n/a,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 13:56:20,1642187733,5/23/2015 13:54:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],in the more radiolucent regions of the,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 13:58:01,1642188071,5/23/2015 13:57:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[LOCATION],[LOCATION],(EMPHYSEMA) in the LUNG,na,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 13:58:01,1642188072,5/23/2015 13:56:55,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(EMPHYSEMA) of the LUNG,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:06:53,1642190076,5/23/2015 14:06:35,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may result from,n,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:28:03,1642195967,5/23/2015 14:26:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],regions of the,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:30:42,1642196973,5/23/2015 14:30:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[LOCATION],[LOCATION],in regions of the,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:38:59,1642198999,5/23/2015 14:38:00,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],in the more radiolucent regions of the,n/a,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:43:43,1642200289,5/23/2015 14:41:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],Asymmetrical pulmonary edema can occur as a result,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:49:53,1642202000,5/23/2015 14:49:18,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",a of or of,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:52:53,1642202761,5/23/2015 14:52:08,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[MANIFESTATION],[MANIFESTATION],more,-,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:52:57,1642202768,5/23/2015 14:52:42,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[LOCATION],[LOCATION],regions of the LUNG,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:53:30,1642202907,5/23/2015 14:53:02,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],in the radiolucent regions,n/a,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204512,5/23/2015 14:55:27,1642203402,5/23/2015 14:53:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],regions of,N/A,244,194,-1,247,204,TWrex-cause,802357-FS1,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA
725204513,5/23/2015 15:15:45,1642208975,5/23/2015 15:15:18,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],FRUCTOSE INTOLERANCE often causes POSTPRANDIAL HYPOGLYCEMIA,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:19:02,1642209924,5/23/2015 15:18:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causes,none,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:19:40,1642210223,5/23/2015 15:19:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES],[CAUSES],causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:20:41,1642210470,5/23/2015 15:19:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes,n/a,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:23:53,1642211541,5/23/2015 15:23:30,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[CAUSES],[CAUSES],most often causes,N/a,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:36:35,1642214887,5/23/2015 15:36:20,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,n/a,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:36:46,1642214969,5/23/2015 15:36:31,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:37:53,1642215322,5/23/2015 15:37:31,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES],[CAUSES],causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:43:47,1642216921,5/23/2015 15:43:18,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[CAUSES],[CAUSES],FRUCTOSE INTOLERANCE,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 15:50:20,1642218780,5/23/2015 15:49:32,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 16:06:14,1642223558,5/23/2015 16:06:00,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES],[CAUSES],causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 16:11:23,1642224934,5/23/2015 16:11:11,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 16:12:02,1642225166,5/23/2015 16:11:34,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],often causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 16:29:12,1642230212,5/23/2015 16:28:35,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CAUSES],[CAUSES],most often causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204513,5/23/2015 16:36:07,1642232247,5/23/2015 16:33:40,false,coinworker,1,20231698,USA,GA,"",172.56.0.166,[CAUSES],[CAUSES],causes,N/A,39,0,1,63,20,TWrex-cause,811861-FS1,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE
725204514,5/23/2015 13:37:59,1642182879,5/23/2015 13:37:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CHRONIC PAIN long acting TRANSDERMAL FENTANYL are usually best.,n/a,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 13:44:08,1642184692,5/23/2015 13:43:39,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],are best.,n/a,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 13:52:19,1642186619,5/23/2015 13:51:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",long acting preparations,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 13:54:23,1642187091,5/23/2015 13:53:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],For CHRONIC PAIN TRANSDERMAL FENTANYL are usually best.,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 13:54:27,1642187104,5/23/2015 13:53:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],For CHRONIC PAIN TRANSDERMAL FENTANYL are best.,na,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:05:01,1642189672,5/23/2015 14:04:35,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],long acting preparations,n,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:21:08,1642194145,5/23/2015 14:19:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],For usually best.,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:28:33,1642196200,5/23/2015 14:27:50,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],are usually best.,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:36:20,1642198372,5/23/2015 14:35:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],For,n/a,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:39:28,1642199175,5/23/2015 14:38:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],"long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:46:25,1642201028,5/23/2015 14:45:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],For,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:50:45,1642202194,5/23/2015 14:50:29,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],preparations,-,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:51:00,1642202223,5/23/2015 14:50:47,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],long acting preparations,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:51:39,1642202372,5/23/2015 14:50:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],preparations,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204514,5/23/2015 14:52:46,1642202691,5/23/2015 14:51:25,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],CHRONIC PAIN,N/A,4,47,-1,15,67,TWrex-cause,803568-FS1,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL
725204515,5/23/2015 13:32:03,1642181277,5/23/2015 13:31:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],EPSTEIN BARR VIRUS associated with EBV INFECTION,n/a,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 13:39:14,1642183165,5/23/2015 13:39:01,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 13:42:41,1642184238,5/23/2015 13:41:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],are associated with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 13:44:48,1642184946,5/23/2015 13:44:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EPSTEIN BARR VIRUS associated with EBV INFECTION,na,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 13:46:29,1642185404,5/23/2015 13:45:54,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EPSTEIN BARR VIRUS are associated with EBV INFECTION,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:00:13,1642188509,5/23/2015 13:59:56,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:01:32,1642188919,5/23/2015 14:00:29,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:18:57,1642193407,5/23/2015 14:18:28,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:19:39,1642193629,5/23/2015 14:19:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:25:07,1642195226,5/23/2015 14:24:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Associated,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:31:24,1642197105,5/23/2015 14:30:56,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:38:26,1642198853,5/23/2015 14:38:08,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:38:34,1642198876,5/23/2015 14:38:15,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],EBV,n/a,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:40:08,1642199251,5/23/2015 14:39:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204515,5/23/2015 14:48:19,1642201582,5/23/2015 14:47:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders Several lymphoproliferative disorders are associated with EBV INFECTION,n/a,119,0,1,131,18,TWrex-cause,810895-FS1,EPSTEIN BARR VIRUS Associated Lymphoproliferative Disorders  Several lymphoproliferative disorders are associated with EBV INFECTION,EBV INFECTION,EPSTEIN BARR VIRUS
725204516,5/23/2015 13:30:52,1642180941,5/23/2015 13:30:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],MYCOPLASMA PNEUMONIA treatment with AZITHROMYCIN,n/a,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:37:29,1642182729,5/23/2015 13:37:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:39:39,1642183382,5/23/2015 13:39:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:42:44,1642184269,5/23/2015 13:42:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],MYCOPLASMA PNEUMONIA treatment with AZITHROMYCIN,na,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:44:34,1642184847,5/23/2015 13:43:50,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],MYCOPLASMA PNEUMONIA treatment with AZITHROMYCIN,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:56:08,1642187683,5/23/2015 13:55:38,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment with,n,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 13:58:09,1642188116,5/23/2015 13:56:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:16:56,1642192851,5/23/2015 14:16:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:18:44,1642193361,5/23/2015 14:18:29,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:21:52,1642194354,5/23/2015 14:21:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:30:14,1642196808,5/23/2015 14:29:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment with,n/a,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:37:08,1642198549,5/23/2015 14:36:39,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treatment with,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:37:09,1642198570,5/23/2015 14:36:39,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:37:14,1642198584,5/23/2015 14:35:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment with,N/A,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204516,5/23/2015 14:46:04,1642200891,5/23/2015 14:44:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION] [TREATS],"[TREATS]
[LOCATION]
[MANIFESTATION]","In animal models of MYCOPLASMA PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",n/a,26,137,-1,46,149,TWrex-cause,800215-FS1,"96   In animal models of  MYCOPLASMA  PNEUMONIA treatment with antimycoplasmal agents such as ketolides, quinolones, clarithromycin, and AZITHROMYCIN also has not eradicated this organism from the respiratory tract.",MYCOPLASMA  PNEUMONIA,AZITHROMYCIN
725204517,5/23/2015 14:56:32,1642203749,5/23/2015 14:56:16,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],to manage,N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 14:57:39,1642203950,5/23/2015 14:57:18,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],A,-,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:00:01,1642204694,5/23/2015 14:59:32,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],administered orally to manage,n/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:03:42,1642205612,5/23/2015 15:02:56,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],calcium channel blocker PRINZMETAL'S ANGINA,N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:04:13,1642205703,5/23/2015 15:02:55,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],to manage,n/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:05:50,1642206104,5/23/2015 15:05:25,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],manage,none,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:05:53,1642206111,5/23/2015 15:05:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],to manage,n/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:05:56,1642206113,5/23/2015 15:04:14,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],"pectoris,",N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:06:30,1642206210,5/23/2015 15:05:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [LOCATION] [SYMPTOM],"[TREATS]
[LOCATION]
[SYMPTOM]","DILTIAZEM A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",n/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:08:04,1642206518,5/23/2015 15:07:35,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[PART_OF],[PART_OF],manage,NA,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:08:29,1642206677,5/23/2015 15:08:09,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",A or or,N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:09:06,1642206865,5/23/2015 15:08:35,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],to manage,N/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:14:07,1642208618,5/23/2015 15:12:15,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],manage,n/a,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:23:04,1642211247,5/23/2015 15:22:42,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],manage,N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204517,5/23/2015 15:30:06,1642213073,5/23/2015 15:29:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",or or,N/A,143,0,-1,161,9,TWrex-cause,804380-FS1,"DILTIAZEM    (                audio )  A calcium channel blocker administered orally or intravenously to manage hypertension, angina pectoris, PRINZMETAL'S ANGINA supraventricular tachyarrhythmias, and rapid ventricular rates in atrial flutter or fibrillation.",PRINZMETAL'S ANGINA,DILTIAZEM
725204518,5/23/2015 15:24:55,1642211882,5/23/2015 15:24:19,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[NONE],[NONE],N/a,Terms not related,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 15:37:40,1642215271,5/23/2015 15:36:57,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],PREGNANCY ISOTRETINOIN,n/a,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 15:37:55,1642215337,5/23/2015 15:37:14,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],receiving,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 15:38:54,1642215634,5/23/2015 15:38:23,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of threatening),N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 15:45:16,1642217291,5/23/2015 15:44:36,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],ISOTRETINOIN,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 15:53:23,1642219731,5/23/2015 15:51:01,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,Pregnant isn't related,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:07:11,1642223831,5/23/2015 16:06:45,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF],[PART_OF],of,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:13:07,1642225441,5/23/2015 16:12:31,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],while receiving,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:14:39,1642226061,5/23/2015 16:14:25,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:30:37,1642230635,5/23/2015 16:30:01,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",occurs while receiving,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:38:15,1642232868,5/23/2015 16:36:08,false,coinworker,1.0,20231698,USA,GA,"",172.56.0.166,[SIDE_EFFECT],[SIDE_EFFECT],occurs while receiving,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:38:15,1642232870,5/23/2015 16:37:14,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CONTRAINDICATES] [MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[CONTRAINDICATES]
[ASSOCIATED_WITH]",risk of severe birth defects while receiving,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:39:17,1642233106,5/23/2015 16:37:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],Extremely high risk severe birth defects,N/A,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:41:34,1642233910,5/23/2015 16:40:12,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",n/a,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204518,5/23/2015 16:51:00,1642237180,5/23/2015 16:50:41,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],short,n/a,115,148,-1,123,160,TWrex-cause,803211-FS1,"Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving ISOTRETINOIN in any amount even for short periods of time; teratogenicity generally characterized by malformations involving craniofacial, cardiovascular, thymus and parathyroid gland, and CNS structures.",PREGNANCY,ISOTRETINOIN
725204519,5/23/2015 14:40:05,1642199238,5/23/2015 14:39:41,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],can result from exposure to,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:51:10,1642202245,5/23/2015 14:50:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:53:54,1642202975,5/23/2015 14:53:42,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],exposure to some,N/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:54:00,1642202986,5/23/2015 14:53:44,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],can result,-,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:03,1642203302,5/23/2015 14:54:38,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],can result from,N/AN/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:16,1642203374,5/23/2015 14:54:32,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[SIDE_EFFECT],[SIDE_EFFECT],can result from,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:31,1642203416,5/23/2015 14:54:46,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],can result from,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:49,1642203581,5/23/2015 14:54:22,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],disorder,N/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:55,1642203611,5/23/2015 14:55:27,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],result from exposure to some,N/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:55:58,1642203621,5/23/2015 14:54:36,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",Malignant hyperthermia (see MALIGNANT HYPERTHERMIA can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:56:29,1642203752,5/23/2015 14:55:36,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",HYPERTHERMIA exposure ANESTHETICS antipsychotics;,N/A,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:57:52,1642204021,5/23/2015 14:57:37,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],result from,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 14:58:30,1642204231,5/23/2015 14:57:44,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],a,mariejackson9333,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 15:00:53,1642204831,5/23/2015 15:00:14,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],result from,none,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204519,5/23/2015 15:02:35,1642205253,5/23/2015 15:01:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],can result from exposure to,n/a,29,87,1,50,98,TWrex-cause,810141-FS1,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS
725204520,5/23/2015 13:30:20,1642180798,5/23/2015 13:29:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatment for ATOPIC DERMATITIS,n/a,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:36:34,1642182419,5/23/2015 13:35:49,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,new sentence,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:38:27,1642182966,5/23/2015 13:37:03,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's nothing in the sentence that expresses a link between the terms.,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:41:35,1642183918,5/23/2015 13:41:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ALLERGIC RHINITIS Treatment for ATOPIC DERMATITIS,na,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:43:08,1642184457,5/23/2015 13:41:49,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],ALLERGIC RHINITIS for ATOPIC DERMATITIS,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:55:12,1642187341,5/23/2015 13:54:34,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",Treatment for,n,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 13:55:36,1642187418,5/23/2015 13:54:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],concurrent may not be effective,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:15:28,1642192461,5/23/2015 14:13:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],See table Drug Treatment for,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:18:08,1642193139,5/23/2015 14:17:52,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treating,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:19:57,1642193687,5/23/2015 14:18:14,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],See table Drug Treatment for ATOPIC DERMATITIS,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:29:44,1642196618,5/23/2015 14:29:03,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],n/a,different subject,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:34:39,1642197884,5/23/2015 14:32:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],itch and rash,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:36:05,1642198283,5/23/2015 14:35:31,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:36:24,1642198385,5/23/2015 14:36:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,different topics,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204520,5/23/2015 14:44:57,1642200632,5/23/2015 14:43:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]","Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash See table Drug Treatment for ATOPIC DERMATITIS",n/a,55,189,1,71,206,TWrex-cause,814068-FS1,"◊ Nonsedating agents during the daytime for concurrent ALLERGIC RHINITIS or conjunctivitis, noting that they may not be effective for treating itch and rash • See table  Drug Treatment for ATOPIC DERMATITIS",ALLERGIC RHINITIS,ATOPIC DERMATITIS
725204521,5/23/2015 15:40:35,1642216104,5/23/2015 15:40:09,false,instagc,1,18805669,CAN,ON,Toronto,76.10.153.80,[PART_OF],[PART_OF],MEN II MEDULLARY THYROID CANCER,n/a,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 15:43:18,1642216792,5/23/2015 15:42:42,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],is,N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 15:49:13,1642218447,5/23/2015 15:48:29,false,neodev,1,32087449,GBR,"","",88.150.208.29,[SYMPTOM],[SYMPTOM],MEN II,N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:09:45,1642224587,5/23/2015 16:09:30,false,neodev,1,31329809,USA,OH,Columbus,64.79.65.23,[IS_A],[IS_A],is,N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:17:36,1642226790,5/23/2015 16:17:23,false,neodev,1,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:34:47,1642231891,5/23/2015 16:34:08,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]","suspected, should be considered,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:43:43,1642234582,5/23/2015 16:42:32,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [OTHER] [NONE],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,"The terms are associated, but there's no word to express the association.",24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:44:06,1642234724,5/23/2015 16:43:29,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],"If suspected,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:46:19,1642235459,5/23/2015 16:45:25,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must excluded before the patient goes surgery.",n/a,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 16:58:50,1642240469,5/23/2015 16:57:54,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"should be considered,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 17:00:57,1642241357,5/23/2015 16:58:54,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],"If is suspected, should be considered,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 17:25:58,1642252359,5/23/2015 17:25:36,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[OTHER],[OTHER],"should be considered,",n/a,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 17:32:45,1642255678,5/23/2015 17:32:15,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,[MANIFESTATION],[MANIFESTATION],"is suspected,",n/a,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 17:33:24,1642256052,5/23/2015 17:32:21,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"If MEN II is suspected, MEDULLARY THYROID should be considered,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204521,5/23/2015 17:39:11,1642258805,5/23/2015 17:38:49,false,neodev,1,14861092,GBR,H3,Leeds,176.252.95.131,[SYMPTOM],[SYMPTOM],"is suspected,",N/A,24,3,1,47,9,TWrex-cause,814347-FS1,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II
725204522,5/23/2015 13:29:21,1642180490,5/23/2015 13:29:00,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY,n/a,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:32:17,1642181330,5/23/2015 13:31:02,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:32:18,1642181346,5/23/2015 13:32:10,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:35:27,1642182076,5/23/2015 13:35:05,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:40:39,1642183701,5/23/2015 13:40:04,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ACETAZOLAMIDE in treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,na,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:41:24,1642183899,5/23/2015 13:40:58,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ACETAZOLAMIDE in treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:52:30,1642186625,5/23/2015 13:50:43,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 13:54:16,1642187049,5/23/2015 13:53:46,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],treatment of,n,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:13:35,1642191930,5/23/2015 14:13:18,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:17:13,1642192950,5/23/2015 14:16:36,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:17:37,1642193030,5/23/2015 14:17:25,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:28:45,1642196252,5/23/2015 14:28:30,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:32:13,1642197296,5/23/2015 14:31:43,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:33:47,1642197624,5/23/2015 14:33:14,false,gifthunterclub,1,30901412,GBR,I3,Gillingham,85.210.125.10,[TREATS],[TREATS],ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS,NONE,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204522,5/23/2015 14:35:02,1642198012,5/23/2015 14:34:41,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,34,0,-1,78,13,TWrex-cause,800864-FS1,ACETAZOLAMIDE in the treatment of ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND effect on gas exchange.,ACUTE MOUNTAIN SICKNESS CLINICAL EFFICACY AND,ACETAZOLAMIDE
725204523,5/23/2015 15:10:54,1642207398,5/23/2015 15:10:00,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]","VIRAL INFECTIONS (eg, HERPES SIMPLEX VIRUS",N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:13:24,1642208397,5/23/2015 15:11:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:13:26,1642208412,5/23/2015 15:12:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],"(eg,",n/a,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:15:43,1642208959,5/23/2015 15:15:02,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],VIRAL INFECTIONS,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:16:06,1642209047,5/23/2015 15:15:45,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",cause with,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:17:38,1642209487,5/23/2015 15:17:16,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[IS_A],[IS_A],"Other VIRAL INFECTIONS (eg, HERPES SIMPLEX VIRUS",N/a,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:33:19,1642213944,5/23/2015 15:32:55,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[IS_A],[IS_A],"(eg,",N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:33:23,1642213962,5/23/2015 15:32:56,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[CAUSES],[CAUSES],VIRAL INFECTIONS SIMPLEX VIRUS cause liver inflammation,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:33:55,1642214058,5/23/2015 15:33:33,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",cause with,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:38:34,1642215517,5/23/2015 15:37:49,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HERPES SIMPLEX VIRUS,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:44:05,1642216985,5/23/2015 15:43:36,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],VIRAL INFECTIONS HERPES SIMPLEX VIRUS,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:47:51,1642218069,5/23/2015 15:47:38,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",may cause liver inflammation,n/a,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 15:48:46,1642218324,5/23/2015 15:48:05,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],"Other (eg,",n/a,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 16:01:13,1642222166,5/23/2015 16:00:55,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",cause with,N/A,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204523,5/23/2015 16:07:50,1642224054,5/23/2015 16:07:39,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,6,45,1,21,65,TWrex-cause,810424-FS1,"Other VIRAL INFECTIONS (eg, cytomegalovirus, HERPES SIMPLEX VIRUS may cause liver inflammation along with their other manifestations.",VIRAL INFECTIONS,HERPES SIMPLEX VIRUS
725204524,5/23/2015 13:35:01,1642182022,5/23/2015 13:34:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],HYPERTENSION caused by PHEOCHROMOCYTOMA,n/a,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 13:41:28,1642183914,5/23/2015 13:41:13,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 13:47:42,1642185656,5/23/2015 13:47:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 13:49:46,1642186123,5/23/2015 13:49:23,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],HYPERTENSION by PHEOCHROMOCYTOMA,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 13:50:18,1642186249,5/23/2015 13:49:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],HYPERTENSION caused by PHEOCHROMOCYTOMA,na,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:02:33,1642189099,5/23/2015 14:02:20,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:10:55,1642191253,5/23/2015 14:09:41,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:21:25,1642194240,5/23/2015 14:21:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:24:59,1642195164,5/23/2015 14:24:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:31:19,1642197096,5/23/2015 14:30:41,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by PHEOCHROMOCYTOMA,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:33:29,1642197559,5/23/2015 14:33:10,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:40:59,1642199453,5/23/2015 14:40:43,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:42:21,1642199969,5/23/2015 14:41:48,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",a drug of of is treatment of,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:45:54,1642200855,5/23/2015 14:44:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204524,5/23/2015 14:50:13,1642202044,5/23/2015 14:49:06,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,136,159,1,147,175,TWrex-cause,812849-FS1,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA
725204525,5/23/2015 15:41:58,1642216406,5/23/2015 15:41:07,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MSA OLIVOPONTOCEREBELLAR ATROPHY distinctive diseases,n/a,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 15:44:50,1642217226,5/23/2015 15:44:05,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,"A service encounter refers to any interaction where you as a customer interacted with a service employee or a service firm, for instance shopping at a retail store, or dining at a restaurant.  In this survey, our aim is to understand customers' awkward service encounters.  To begin, please take a moment to think of a past service encounter which you would label as awkward.  Try and remember exactly what happened and what it was like being in that encounter.",98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 15:50:11,1642218712,5/23/2015 15:49:40,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],MSA,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:10:43,1642224841,5/23/2015 16:10:18,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF],[PART_OF],of,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:18:08,1642226991,5/23/2015 16:17:54,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:36:25,1642232367,5/23/2015 16:35:43,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",has supplanted the former terms,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:44:35,1642234948,5/23/2015 16:44:13,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[IS_A],[IS_A],has supplanted the former terms,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:45:32,1642235187,5/23/2015 16:44:56,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],same condition.,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 16:53:41,1642238380,5/23/2015 16:52:49,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MSA supplanted former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",n/a,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:00:58,1642241364,5/23/2015 17:00:12,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],different expressions of the same condition.,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:02:45,1642242203,5/23/2015 17:01:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],simply different expressions of the same condition.,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:27:28,1642253123,5/23/2015 17:26:30,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],simply different expressions of the same condition.,n/a,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:33:59,1642256283,5/23/2015 17:33:18,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],The term MSA has supplanted the former terms,n/a,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:35:13,1642256893,5/23/2015 17:34:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],MSA has supplanted terms OLIVOPONTOCEREBELLAR ATROPHY,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204525,5/23/2015 17:40:21,1642259311,5/23/2015 17:39:47,false,neodev,1.0,14861092,GBR,H3,Leeds,176.252.95.131,[OTHER],[OTHER],supplanted the former terms,N/A,98,9,1,125,12,TWrex-cause,814350-FS1,"The term MSA has supplanted the former terms Shy Drager syndrome, striatonigral degeneration, and OLIVOPONTOCEREBELLAR ATROPHY because it has come to be understood that these seemingly distinctive diseases are simply different expressions of the same condition.",OLIVOPONTOCEREBELLAR ATROPHY,MSA
725204526,5/23/2015 15:09:59,1642207162,5/23/2015 15:09:25,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]","RSD persistent, REGIONAL PAIN proportion to injury;",N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:11:42,1642207722,5/23/2015 15:10:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,none,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:12:53,1642208179,5/23/2015 15:11:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]","characteristic, persistent,",n/a,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:15:00,1642208853,5/23/2015 15:14:29,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],trauma;,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:15:42,1642208955,5/23/2015 15:15:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with a of or by,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:17:14,1642209380,5/23/2015 15:16:40,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[MANIFESTATION],[MANIFESTATION],in all patients with a history of,N/a,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:32:54,1642213829,5/23/2015 15:32:03,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],"characteristic,",N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:32:55,1642213837,5/23/2015 15:32:23,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DIAGNOSIS RSD REGIONAL PAIN,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:33:30,1642213993,5/23/2015 15:32:50,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [ASSOCIATED_WITH] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a of or by symptoms.,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:37:44,1642215291,5/23/2015 15:37:13,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],RSD,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:40:57,1642216162,5/23/2015 15:40:21,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],with a history of,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:43:35,1642216839,5/23/2015 15:42:58,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],RSD REGIONAL PAIN,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:47:38,1642217979,5/23/2015 15:45:31,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","characteristic, persistent, REGIONAL PAIN",n/a,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 15:48:02,1642218135,5/23/2015 15:46:47,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],patients with,n/a,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204526,5/23/2015 16:00:53,1642222059,5/23/2015 15:59:44,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a of of by,N/A,125,51,1,137,54,TWrex-cause,814592-FS1,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD
725204527,5/23/2015 15:13:36,1642208428,5/23/2015 15:13:07,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",(RCTs) compared PRIMARY G CSF PROPHYLAXIS NEUTROPENIA onset),N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:15:59,1642209009,5/23/2015 15:15:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",(given during the first cycle and before onset),n/a,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:16:42,1642209234,5/23/2015 15:15:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],(given during,none,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:18:02,1642209607,5/23/2015 15:17:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with or with a,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:18:22,1642209690,5/23/2015 15:17:44,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],tumor malignant lymphoma.,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:21:39,1642210778,5/23/2015 15:20:26,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[NONE],[NONE],N/a,No relation between the terms,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:35:08,1642214368,5/23/2015 15:34:45,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],before,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:35:17,1642214418,5/23/2015 15:34:43,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[TREATS] [SIDE_EFFECT],"[TREATS]
[SIDE_EFFECT]",PRIMARY G CSF PROPHYLAXIS chemotherapy NEUTROPENIA,n/a,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:36:10,1642214709,5/23/2015 15:35:37,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with or with a or,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:41:30,1642216269,5/23/2015 15:40:53,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],NEUTROPENIA,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:48:01,1642218109,5/23/2015 15:46:06,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[MANIFESTATION],[MANIFESTATION],PRIMARY CSF PROPHYLAXIS before NEUTROPENIA onset),N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:50:45,1642218944,5/23/2015 15:50:29,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treatment in adult patients,n/a,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 15:56:05,1642220442,5/23/2015 15:53:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],(given before,n/a,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 16:04:48,1642223235,5/23/2015 16:04:11,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with or treatment with a or,N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204527,5/23/2015 16:09:45,1642224589,5/23/2015 16:09:18,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],before onset),N/A,163,83,-1,173,108,TWrex-cause,803581-FS1,Study selection and assessment:  Randomized controlled trials (RCTs) that compared PRIMARY G CSF PROPHYLAXIS (given during the first chemotherapy cycle and before NEUTROPENIA onset) with placebo or no treatment in adult patients with cancer receiving conventional dose chemotherapy for a solid tumor or malignant lymphoma.,NEUTROPENIA,PRIMARY G CSF PROPHYLAXIS
725204528,5/23/2015 13:38:57,1642183079,5/23/2015 13:38:43,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ASPIRIN therapy for MYOCARDIAL INFARCTION,n/a,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 13:44:53,1642184977,5/23/2015 13:44:35,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 13:53:41,1642186841,5/23/2015 13:53:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],therapy for,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 13:56:08,1642187694,5/23/2015 13:55:38,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ASPIRIN therapy for MYOCARDIAL INFARCTION,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 13:56:57,1642187835,5/23/2015 13:56:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ASPIRIN for MYOCARDIAL INFARCTION,na,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:06:11,1642189923,5/23/2015 14:05:44,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],therapy for,n,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:23:59,1642194912,5/23/2015 14:22:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:29:14,1642196454,5/23/2015 14:28:33,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Addition for,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:37:09,1642198559,5/23/2015 14:36:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy,n/a,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:40:53,1642199419,5/23/2015 14:40:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],therapy,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:48:52,1642201723,5/23/2015 14:48:13,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:51:42,1642202391,5/23/2015 14:51:21,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],therapy,-,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:52:13,1642202565,5/23/2015 14:51:58,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],therapy for,N/A,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:52:38,1642202661,5/23/2015 14:51:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,n/a,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204528,5/23/2015 14:54:07,1642203038,5/23/2015 14:52:33,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],therapy for,n/a,106,69,-1,126,76,TWrex-cause,804032-FS1,"Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.",MYOCARDIAL INFARCTION,ASPIRIN
725204529,5/23/2015 15:16:24,1642209126,5/23/2015 15:15:47,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",INVASIVE ASPERGILLOSIS AMPHOTERICIN LIPOSOMAL,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:19:38,1642210197,5/23/2015 15:19:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:20:00,1642210284,5/23/2015 15:19:43,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",drug of of,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:20:55,1642210555,5/23/2015 15:20:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],primary treatment of,n/a,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:24:17,1642211677,5/23/2015 15:23:55,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],treatment of,N/a,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:36:55,1642215014,5/23/2015 15:36:37,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[LOCATION] [TREATS],"[TREATS]
[LOCATION]",IDSA treatment INVASIVE ASPERGILLOSIS,n/a,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:37:12,1642215092,5/23/2015 15:36:47,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:38:19,1642215441,5/23/2015 15:37:56,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",drug of treatment of,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:44:32,1642217099,5/23/2015 15:43:50,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IV AMPHOTERICIN B LIPOSOMAL,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 15:51:00,1642219089,5/23/2015 15:50:21,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],INVASIVE ASPERGILLOSIS IV AMPHOTERICIN B LIPOSOMAL,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 16:06:42,1642223661,5/23/2015 16:06:17,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",drug of of,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 16:12:29,1642225307,5/23/2015 16:12:03,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment preferred alternative.,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 16:14:22,1642225894,5/23/2015 16:11:26,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 16:29:53,1642230393,5/23/2015 16:29:16,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",for primary of,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204529,5/23/2015 16:37:13,1642232565,5/23/2015 16:34:57,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],treatment of alternative.,N/A,149,193,-1,170,220,TWrex-cause,800199-FS1,"244 ,   248 ,   268 ,   269 ,   288 ,   396 ,   379 ,   420 ,   423 ,   436  IDSA considers voriconazole the drug of choice for primary treatment of INVASIVE ASPERGILLOSIS in most patients and IV AMPHOTERICIN B LIPOSOMAL the preferred alternative.",INVASIVE ASPERGILLOSIS,IV AMPHOTERICIN B LIPOSOMAL
725204530,5/23/2015 15:38:44,1642215540,5/23/2015 15:38:05,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH],[ASSOCIATED_WITH],response PSORIASIS BETAMETHASONE VALERATE,n/a,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 15:38:45,1642215544,5/23/2015 15:38:18,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],response,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 15:39:45,1642215860,5/23/2015 15:39:24,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 15:46:29,1642217670,5/23/2015 15:45:53,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],BETAMETHASONE VALERATE,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:08:11,1642224136,5/23/2015 16:07:45,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",of a,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:14:06,1642225817,5/23/2015 16:13:50,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],response to,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:15:34,1642226228,5/23/2015 16:15:24,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:31:52,1642230995,5/23/2015 16:31:23,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],The response to,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:40:28,1642233541,5/23/2015 16:39:24,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],response of PSORIASIS to,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:40:46,1642233653,5/23/2015 16:40:04,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],response to,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:42:53,1642234277,5/23/2015 16:42:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],response PSORIASIS to BETAMETHASONE VALERATE clobetasol propionate: month controlled study.,n/a,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:54:30,1642238710,5/23/2015 16:53:31,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],controlled study.,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 16:57:04,1642239728,5/23/2015 16:55:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],response of,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 17:21:16,1642249979,5/23/2015 17:20:57,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],response of,n/a,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204530,5/23/2015 17:31:30,1642255034,5/23/2015 17:30:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],response of PSORIASIS to BETAMETHASONE VALERATE,N/A,16,29,-1,24,51,TWrex-cause,804799-FS1,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE
725204531,5/23/2015 13:39:48,1642183401,5/23/2015 13:39:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],PMR does not cause MUSCLE WEAKNESS,n/a,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 13:46:26,1642185393,5/23/2015 13:45:57,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[OTHER],[OTHER],does not cause,n/a,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 13:56:41,1642187771,5/23/2015 13:56:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],does not cause,N/A,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 13:58:23,1642188169,5/23/2015 13:58:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],PMR does not cause MUSCLE WEAKNESS,na,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 13:58:39,1642188257,5/23/2015 13:58:03,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],PMR does not cause MUSCLE WEAKNESS,N/A,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:07:16,1642190228,5/23/2015 14:06:53,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],does not cause,n,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:29:27,1642196536,5/23/2015 14:28:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],does not cause,N/A,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:31:25,1642197113,5/23/2015 14:30:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],does not cause,DOES NOT CAUSE,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:39:17,1642199120,5/23/2015 14:39:00,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],does not cause,n/a,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:44:39,1642200534,5/23/2015 14:43:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],not cause MUSCLE WEAKNESS although pain may limit muscular effort.,N/A,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:50:16,1642202071,5/23/2015 14:49:56,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES],[CAUSES],cause,N/A,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:53:24,1642202886,5/23/2015 14:52:59,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],does not cause,Doesn't cause,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:53:28,1642202890,5/23/2015 14:52:55,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],does not cause,-,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:54:08,1642203046,5/23/2015 14:53:32,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER],[OTHER],does not cause,n/a,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204531,5/23/2015 14:54:34,1642203209,5/23/2015 14:53:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,n/a,19,0,1,66,3,TWrex-cause,814877-FS1,PMR does not cause MUSCLE WEAKNESS although pain may limit muscular effort.,MUSCLE WEAKNESS,PMR
725204532,5/23/2015 13:39:13,1642183159,5/23/2015 13:38:59,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],n/a,not sure the relationshiop,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 13:45:13,1642185104,5/23/2015 13:44:53,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 13:54:51,1642187262,5/23/2015 13:53:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,The two terms don't appear to be related.,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 13:56:54,1642187800,5/23/2015 13:56:09,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,None match,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 13:57:28,1642187957,5/23/2015 13:57:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BC] Obtain history on DYSPNEA,na,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:06:34,1642189971,5/23/2015 14:06:12,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],careful history,n,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:26:33,1642195644,5/23/2015 14:24:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],history focusing on,N/A,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:30:09,1642196752,5/23/2015 14:29:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],a careful history,N/A,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:37:59,1642198762,5/23/2015 14:37:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],"recent systemic illnesses,",n/a,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:41:46,1642199823,5/23/2015 14:40:56,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[NONE],[NONE],N/A,npt related,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:49:15,1642201821,5/23/2015 14:48:55,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:52:07,1642202513,5/23/2015 14:51:44,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],Examination,-,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:52:41,1642202671,5/23/2015 14:52:14,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[NONE],[NONE],N/A,Too hard to determine as they don't appear connected,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:53:44,1642202956,5/23/2015 14:52:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [MANIFESTATION] [LOCATION],"[LOCATION]
[SYMPTOM]
[MANIFESTATION]","Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",n/a,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204532,5/23/2015 14:54:22,1642203163,5/23/2015 14:52:48,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],"illnesses, fever, chest pain, DYSPNEA",N/A,130,0,1,136,3,TWrex-cause,812612-FS1,"BC]  History and Physical Examination  3.1 Obtain a careful history focusing on recent systemic illnesses, fever, chest pain, and DYSPNEA",DYSPNEA,BC
725204533,5/23/2015 14:51:42,1642202393,5/23/2015 14:51:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:54:09,1642203045,5/23/2015 14:53:55,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PREVENTS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",comparison of,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:54:44,1642203236,5/23/2015 14:54:02,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],comparison,-,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:55:19,1642203373,5/23/2015 14:55:05,false,neodev,1.0,30504276,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:55:40,1642203440,5/23/2015 14:55:18,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],double blind comparison,n/a,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:56:14,1642203692,5/23/2015 14:55:33,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for,n/a,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:56:48,1642203811,5/23/2015 14:55:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",n/a,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:56:52,1642203818,5/23/2015 14:55:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],for complicated,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:57:27,1642203932,5/23/2015 14:56:30,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],comparison SULFAMETHOXAZOLE URINARY TRACT INFECTIONS,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:58:10,1642204102,5/23/2015 14:57:53,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],for,n/a,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:58:21,1642204203,5/23/2015 14:55:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],TRACT INFECTIONS,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 14:59:03,1642204416,5/23/2015 14:58:38,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 15:01:29,1642204944,5/23/2015 15:00:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],for,none,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 15:01:51,1642205091,5/23/2015 15:00:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],double blind comparison of for complicated,n/a,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204533,5/23/2015 15:02:23,1642205203,5/23/2015 15:00:19,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[TREATS],[TREATS],"Randomized, double blind comparison",the medicine treats it,143,97,-1,166,126,TWrex-cause,800514-FS1,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725204534,5/23/2015 15:09:02,1642206830,5/23/2015 15:07:58,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[MANIFESTATION],[MANIFESTATION],"WARFARIN crosses placenta, abnormalities later GESTATION",N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:09:49,1642207053,5/23/2015 15:09:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,none,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:10:27,1642207266,5/23/2015 15:09:45,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],has been associated with fetal hemorrhage when used later,n/a,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:12:33,1642208085,5/23/2015 15:11:43,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],GESTATION,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:14:38,1642208751,5/23/2015 15:14:13,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is with,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:15:47,1642208977,5/23/2015 15:14:54,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[NONE],[NONE],N/a,No relation between the two terms,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:16:24,1642209133,5/23/2015 15:14:57,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",n/a,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:22:19,1642210999,5/23/2015 15:22:01,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,-,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:31:36,1642213463,5/23/2015 15:30:57,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[OTHER],[OTHER],used,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:31:47,1642213519,5/23/2015 15:31:22,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:31:51,1642213567,5/23/2015 15:31:25,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"WARFARIN first trimester, associated hemorrhage central nervous system abnormalities GESTATION",N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:36:29,1642214838,5/23/2015 15:35:57,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],GESTATION,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:39:15,1642215750,5/23/2015 15:38:48,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CONTRAINDICATES],[CONTRAINDICATES],abnormalities when used,N/A,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:42:11,1642216508,5/23/2015 15:41:18,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,The gestation of a pregnancy isn't related to the drug.,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204534,5/23/2015 15:44:58,1642217252,5/23/2015 15:44:25,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],when used in,n/a,193,13,-1,201,21,TWrex-cause,803190-FS1,"Rationale: • WARFARIN crosses the placenta, is teratogenic during the first trimester, and has been associated with fetal hemorrhage and central nervous system abnormalities when used later in GESTATION",GESTATION,WARFARIN
725204535,5/23/2015 15:39:01,1642215654,5/23/2015 15:38:47,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 15:39:03,1642215669,5/23/2015 15:38:46,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[TREATS],[TREATS],VALPROIC ACID treatment BIPOLAR,n/a,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 15:40:15,1642216018,5/23/2015 15:39:48,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]",is with treatment of,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 15:46:58,1642217849,5/23/2015 15:46:33,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],VALPROIC ACID,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:08:42,1642224232,5/23/2015 16:08:15,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [TREATS] [ASSOCIATED_WITH] [PART_OF],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is treatment with treatment of,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:14:23,1642225895,5/23/2015 16:14:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:16:38,1642226542,5/23/2015 16:15:36,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:32:24,1642231220,5/23/2015 16:31:55,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],maintenance treatment of,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:41:07,1642233755,5/23/2015 16:40:28,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],maintenance treatment of,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:41:11,1642233778,5/23/2015 16:40:47,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],maintenance treatment,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:43:34,1642234534,5/23/2015 16:42:54,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],VALPROIC ACID for both acute mania maintenance treatment of BIPOLAR DISORDER,n/a,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:54:43,1642238770,5/23/2015 16:54:31,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 16:57:37,1642239923,5/23/2015 16:57:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],approved as adjunct treatment with,N/A,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 17:22:20,1642250531,5/23/2015 17:21:19,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment,n/a,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204535,5/23/2015 17:34:47,1642256754,5/23/2015 17:34:01,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],approved as adjunct treatment with VALPROIC ACID,n/a,147,83,-1,162,96,TWrex-cause,800080-FS1,"106 , 107   Furthermore, it is also approved as adjunct treatment with lithium and VALPROIC ACID for both acute mania and maintenance treatment of BIPOLAR DISORDER",BIPOLAR DISORDER,VALPROIC ACID
725204536,5/23/2015 15:39:17,1642215773,5/23/2015 15:39:02,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 15:39:49,1642215893,5/23/2015 15:39:04,false,instagc,1.0,18805669,CAN,ON,Toronto,76.10.153.80,[TREATS],[TREATS],(LEUPROLIDE ACETATE treatment ENDOMETRIOSIS:,n/a,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 15:40:40,1642216110,5/23/2015 15:40:17,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 15:47:33,1642217970,5/23/2015 15:47:02,false,neodev,1.0,32087449,GBR,"","",88.150.208.29,[TREATS],[TREATS],(LEUPROLIDE ACETATE,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:09:05,1642224369,5/23/2015 16:08:46,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:14:53,1642226085,5/23/2015 16:14:24,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:17:08,1642226649,5/23/2015 16:16:43,false,neodev,1.0,32103286,USA,CA,Torrance,66.171.228.149,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:33:03,1642231393,5/23/2015 16:32:31,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],in the treatment of,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:41:33,1642233899,5/23/2015 16:41:08,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment of,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:41:35,1642233933,5/23/2015 16:41:12,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:44:23,1642234919,5/23/2015 16:43:35,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],(LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS:,n/a,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:55:00,1642238847,5/23/2015 16:54:45,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 16:57:59,1642240072,5/23/2015 16:57:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the treatment of,N/A,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 17:22:35,1642250606,5/23/2015 17:22:21,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment of,n/a,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204536,5/23/2015 17:31:31,1642255040,5/23/2015 17:31:06,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],in the treatment of,n/a,111,49,-1,123,68,TWrex-cause,800480-FS1,"1]  Dlugi AM, Miller JD, Knittle J. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
725204537,5/23/2015 13:32:22,1642181365,5/23/2015 13:32:04,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],WARFARIN for STROKE prevention,nA,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 13:39:37,1642183367,5/23/2015 13:39:15,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],prevention,n/a,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 13:43:15,1642184463,5/23/2015 13:42:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 13:45:22,1642185113,5/23/2015 13:44:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],WARFARIN for STROKE prevention,na,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 13:46:54,1642185527,5/23/2015 13:46:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],WARFARIN for STROKE prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:00:47,1642188662,5/23/2015 14:00:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Treatment of,n,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:02:37,1642189102,5/23/2015 14:01:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:19:18,1642193495,5/23/2015 14:18:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:20:02,1642193708,5/23/2015 14:19:41,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:25:41,1642195388,5/23/2015 14:25:10,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],STROKE prevention,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:31:50,1642197201,5/23/2015 14:31:25,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],for prevention,n/a,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:39:00,1642198993,5/23/2015 14:38:29,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [IS_A] [TREATS] [PART_OF],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",an with Treatment of,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:39:05,1642199066,5/23/2015 14:38:36,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:40:55,1642199439,5/23/2015 14:40:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention in,N/A,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204537,5/23/2015 14:49:28,1642201882,5/23/2015 14:48:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA):",n/a,28,0,-1,33,8,TWrex-cause,805013-FS1,"WARFARIN versus aspirin for STROKE prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.",STROKE,WARFARIN
725204538,5/23/2015 14:56:45,1642203800,5/23/2015 14:56:34,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],the most effective treatment,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 14:57:54,1642204032,5/23/2015 14:57:41,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:00:43,1642204800,5/23/2015 15:00:02,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],most effective,n/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:04:23,1642205744,5/23/2015 15:03:43,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],ETHOSUXIMIDE effective treatment CHILDHOOD ABSENCE EPILEPSY,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:04:57,1642205893,5/23/2015 15:04:14,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment for,n/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:06:21,1642206178,5/23/2015 15:05:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],treatment,none,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:06:46,1642206271,5/23/2015 15:05:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],most effective treatment for,n/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:06:53,1642206296,5/23/2015 15:05:57,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],ETHOSUXIMIDE,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:07:32,1642206401,5/23/2015 15:06:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,n/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:08:37,1642206716,5/23/2015 15:08:06,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[TREATS],[TREATS],effective treatment,NA,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:09:12,1642206884,5/23/2015 15:08:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]",a of treatment,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:09:28,1642206974,5/23/2015 15:09:08,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],effective treatment for,N/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:16:13,1642209084,5/23/2015 15:14:09,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:23:25,1642211360,5/23/2015 15:23:06,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204538,5/23/2015 15:25:27,1642212091,5/23/2015 15:24:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]",a of treatment,N/A,136,86,-1,161,98,TWrex-cause,804166-FS1,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE
725204539,5/23/2015 13:38:41,1642183041,5/23/2015 13:38:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],THYROID STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE;,n/a,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 13:44:34,1642184848,5/23/2015 13:44:09,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,jibberish,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 13:53:12,1642186760,5/23/2015 13:52:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There is nothing linking the terms together.,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 13:55:36,1642187421,5/23/2015 13:54:25,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],N/A,"none of the catagories match, its just a bunch of drug names",217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 13:56:39,1642187766,5/23/2015 13:54:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TSH THYROID STIMULATING HORMONE; FSH = FOLLICLE STIMULATING HORMONE;,na,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:05:44,1642189852,5/23/2015 14:05:02,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[IS_A],[IS_A],Inhibit,n,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:21:40,1642194325,5/23/2015 14:19:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Insulin Inhibit HORMONE; luteinizing hormone;,N/A,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:22:46,1642194684,5/23/2015 14:21:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],Inhibit,N/A,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:36:42,1642198484,5/23/2015 14:36:22,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],hormone.,n/a,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:40:20,1642199305,5/23/2015 14:39:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],releasing hormone,N/A,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:48:10,1642201526,5/23/2015 14:46:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[OTHER],[OTHER],Dopamine,N/A,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:51:19,1642202259,5/23/2015 14:50:46,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],releasing,-,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:51:55,1642202466,5/23/2015 14:51:02,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[OTHER],[OTHER],=,Its a list,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:53:01,1642202772,5/23/2015 14:51:38,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[PART_OF],[PART_OF],TSH,n/a,217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204539,5/23/2015 14:53:24,1642202883,5/23/2015 14:51:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"No relation evident, seems just a bunch of acronym definitions presented.",217,284,-1,249,312,TWrex-cause,803111-FS1,Dopamine Prolactin LH FSH TSH Inhibit Inhibit Inhibit Inhibit      Corticotropin releasing hormone ACTH Stimulate      Growth hormone releasing hormone GH Stimulate Somatostatin GH TSH Insulin Inhibit Inhibit Inhibit TSH = THYROID STIMULATING HORMONE; LH = luteinizing hormone; FSH = FOLLICLE STIMULATING HORMONE; ACTH = adrenocorticotropic hormone (corticotropin); GH = growth hormone.,TSH = THYROID STIMULATING HORMONE,FOLLICLE STIMULATING HORMONE
725204540,5/23/2015 13:32:45,1642181451,5/23/2015 13:32:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"ALLERGIC CONTACT DERMATITIS is DELAYED HYPERSENSITIVITY REACTION in the skin,",n/a,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 13:40:01,1642183465,5/23/2015 13:39:38,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],is a,n/a,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 13:44:41,1642184918,5/23/2015 13:43:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is a,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 13:46:31,1642185414,5/23/2015 13:45:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ALLERGIC CONTACT DERMATITIS is a DELAYED HYPERSENSITIVITY REACTION,na,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 13:47:30,1642185630,5/23/2015 13:46:56,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],"ALLERGIC CONTACT DERMATITIS is a type 4, mediated, DELAYED HYPERSENSITIVITY REACTION",N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:01:06,1642188778,5/23/2015 14:00:48,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involving,n,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:04:07,1642189452,5/23/2015 14:02:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],is a,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:19:45,1642193646,5/23/2015 14:19:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[IS_A],[IS_A],is a,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:20:20,1642193801,5/23/2015 14:20:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[IS_A],[IS_A],is a,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:26:31,1642195612,5/23/2015 14:25:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION",N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:32:08,1642197287,5/23/2015 14:31:51,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],is a,n/a,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:39:19,1642199140,5/23/2015 14:39:06,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],is a,n/a,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:40:13,1642199290,5/23/2015 14:39:03,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is a,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:41:34,1642199720,5/23/2015 14:40:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],is a type,N/A,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204540,5/23/2015 14:48:41,1642201698,5/23/2015 14:48:22,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[IS_A],[IS_A],is a,-,0,87,1,26,120,TWrex-cause,812187-FS1,"ALLERGIC CONTACT DERMATITIS is a type 4, T cell mediated, DELAYED HYPERSENSITIVITY REACTION in the skin, involving both innate and adaptive immunity.",ALLERGIC CONTACT DERMATITIS,DELAYED HYPERSENSITIVITY REACTION
725204541,5/23/2015 13:33:37,1642181694,5/23/2015 13:32:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],CHICKENPOX herpes zoster,n/a,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 13:40:31,1642183642,5/23/2015 13:40:02,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],(see,n/a,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 13:45:32,1642185143,5/23/2015 13:44:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],(see,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 13:47:18,1642185599,5/23/2015 13:46:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CHICKENPOX being the acute invasive phase of HERPES ZOSTER.,na,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 13:48:06,1642185744,5/23/2015 13:47:30,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],Chickenpox is caused by herpes zoster,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:01:29,1642188870,5/23/2015 14:01:07,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],reactivation of,n,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:06:34,1642189969,5/23/2015 14:04:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:20:38,1642193940,5/23/2015 14:20:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],phase,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:22:38,1642194648,5/23/2015 14:21:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],acute invasive phase and reactivation of the latent phase,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:27:28,1642195886,5/23/2015 14:26:34,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],representing reactivation of the latent phase (see HERPES ZOSTER.,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:32:31,1642197337,5/23/2015 14:32:09,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],representing reactivation,n/a,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:39:37,1642199184,5/23/2015 14:39:20,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PART_OF],[PART_OF],phase,n/a,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:40:44,1642199374,5/23/2015 14:40:17,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",is caused by of of,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:43:15,1642200183,5/23/2015 14:41:35,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",is caused by,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204541,5/23/2015 14:49:11,1642201812,5/23/2015 14:48:37,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",being the acute invasive phase of,N/A,79,215,1,88,228,TWrex-cause,812462-FS1,"Chickenpox is caused by the varicella zoster virus (human herpesvirus type 3), CHICKENPOX being the acute invasive phase of the virus and herpes zoster (shingles) representing reactivation of the latent phase (see  HERPES ZOSTER.",CHICKENPOX,HERPES ZOSTER
725204542,5/23/2015 14:57:01,1642203827,5/23/2015 14:56:46,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[TREATS],[TREATS],treatment:,N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 14:58:08,1642204094,5/23/2015 14:57:56,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment:,-,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:01:32,1642204951,5/23/2015 15:00:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER],[OTHER],double blind study,n/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:05:05,1642205900,5/23/2015 15:04:24,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],plus PROPRANOLOL essential HYPERTENSION,N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:06:13,1642206163,5/23/2015 15:04:58,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment: in,n/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:06:42,1642206258,5/23/2015 15:06:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],treatment:,none,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:07:03,1642206342,5/23/2015 15:06:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment:,n/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:07:18,1642206378,5/23/2015 15:06:57,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HYPERTENSION,N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:09:09,1642206873,5/23/2015 15:08:38,false,prodege,1.0,1919444,GBR,D1,Darlington,86.22.61.205,[MANIFESTATION],[MANIFESTATION],treatment:,NA,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:09:38,1642206995,5/23/2015 15:07:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment:",n/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:09:50,1642207083,5/23/2015 15:09:19,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS],"[TREATS]
[IS_A]","A, treatment:",N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:09:59,1642207157,5/23/2015 15:09:30,false,prodege,1.0,22031444,GBR,K6,Portsmouth,78.146.11.229,[TREATS],[TREATS],treatment:,N/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:16:48,1642209265,5/23/2015 15:16:15,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment:,n/a,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:23:49,1642211501,5/23/2015 15:23:26,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment:,N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204542,5/23/2015 15:25:54,1642212203,5/23/2015 15:25:31,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS],"[TREATS]
[IS_A]","A, treatment: a",N/A,222,197,-1,233,208,TWrex-cause,804202-FS1,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL
725204543,5/23/2015 13:35:54,1642182233,5/23/2015 13:35:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BRUCELLOSIS caused by BRUCELLA MELITENSIS.,n/a,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 13:42:00,1642184038,5/23/2015 13:41:45,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 13:48:28,1642185844,5/23/2015 13:48:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 13:50:44,1642186352,5/23/2015 13:50:13,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",BRUCELLOSIS + caused by BRUCELLA MELITENSIS.,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 13:51:20,1642186448,5/23/2015 13:50:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],BRUCELLOSIS caused by BRUCELLA MELITENSIS.,na,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:03:07,1642189196,5/23/2015 14:02:52,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Treatment,n,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:13:44,1642192004,5/23/2015 14:12:23,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:21:56,1642194356,5/23/2015 14:21:43,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:25:47,1642195419,5/23/2015 14:25:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:33:12,1642197514,5/23/2015 14:32:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:34:11,1642197734,5/23/2015 14:33:53,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:42:00,1642199930,5/23/2015 14:41:50,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:43:06,1642200160,5/23/2015 14:42:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:46:52,1642201166,5/23/2015 14:46:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
725204543,5/23/2015 14:49:35,1642201937,5/23/2015 14:49:24,false,elite,1.0,31856422,GBR,C9,Carlisle,92.19.36.179,[CAUSES],[CAUSES],caused by,N/A,79,109,1,89,128,TWrex-cause,811413-FS1,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS
